Uneven	O
X	B-DNA
inactivation	O
in	O
a	O
female	O
monozygotic	O
twin	O
pair	O
with	O
Fabry	O
disease	O
and	O
discordant	O
expression	O
of	O
a	O
novel	O
mutation	O
in	O
the	O
alpha-galactosidase	B-DNA
A	I-DNA
gene	I-DNA
.	O

We	O
describe	O
two	O
female	O
monozygotic	O
(	O
MZ	O
)	O
twins	O
heterozygous	O
for	O
Fabry	O
disease	O
,	O
an	O
X	O
linked	O
disorder	O
resulting	O
from	O
the	O
deficient	O
activity	O
of	O
alpha-galactosidase	B-protein
A	I-protein
.	O

While	O
one	O
of	O
the	O
twins	O
was	O
clinically	O
affected	O
,	O
the	O
other	O
was	O
asymptomatic	O
.	O

Enzymatic	O
assay	O
of	O
alpha-galactosidase	B-protein
in	O
blood	B-cell_type
leucocytes	I-cell_type
,	O
skin	B-cell_type
fibroblasts	I-cell_type
,	O
Epstein-Barr	B-cell_line
virus	I-cell_line
transformed	I-cell_line
lymphoid	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
and	O
hair	O
follicles	O
of	O
the	O
twins	O
and	O
their	O
parents	O
confirmed	O
the	O
heterozygous	O
status	O
of	O
the	O
twins	O
and	O
indicated	O
that	O
Fabry	O
disease	O
had	O
occurred	O
as	O
a	O
result	O
of	O
a	O
de	O
novo	O
mutation	O
.	O

The	O
son	O
of	O
the	O
unaffected	O
twin	O
sister	O
was	O
shown	O
to	O
be	O
hemizygous	O
.	O

Molecular	O
analysis	O
of	O
the	O
alpha-galactosidase	B-DNA
A	I-DNA
gene	I-DNA
permitted	O
the	O
identification	O
of	O
an	O
as	O
yet	O
undescribed	O
point	O
mutation	O
at	O
position	B-DNA
10182	I-DNA
of	I-DNA
exon	I-DNA
5	I-DNA
which	O
causes	O
an	O
Asp	O
to	O
Asn	O
substitution	O
at	O
codon	B-DNA
231	I-DNA
.	O

Single	O
strand	O
conformation	O
polymorphism	O
(	O
SSCP	O
)	O
analysis	O
again	O
showed	O
the	O
heterozygous	O
status	O
of	O
the	O
twins	O
and	O
a	O
normal	O
pattern	O
in	O
their	O
parents	O
.	O

The	O
basis	O
for	O
the	O
discordant	O
expression	O
of	O
this	O
d	O
novo	O
mutation	O
in	O
the	O
twins	O
was	O
investigated	O
by	O
studying	O
their	O
X	O
inactivation	O
status	O
.	O

Analysis	O
of	O
the	O
inactive	B-DNA
X	I-DNA
specific	O
methylation	O
at	O
the	O
androgen	B-DNA
receptor	I-DNA
gene	I-DNA
showed	O
unbalanced	O
inactivation	O
in	O
the	O
twins	O
'	O
fibroblasts	O
and	O
in	O
opposite	O
directions	O
.	O

While	O
the	O
maternally	B-DNA
derived	I-DNA
X	I-DNA
chromosome	I-DNA
was	O
preferentially	O
active	O
in	O
the	O
asymptomatic	O
twin	O
,	O
the	O
paternal	B-DNA
X	I-DNA
chromosome	I-DNA
was	O
active	O
in	O
the	O
other	O
,	O
affected	O
twin	O
and	O
was	O
found	O
in	O
her	O
hemizygotic	O
nephew	O
.	O

These	O
data	O
suggest	O
that	O
the	O
paternal	B-DNA
X	I-DNA
chromosome	I-DNA
carries	O
the	O
de	O
novo	O
alpha-galactosidase	B-protein
A	I-protein
mutation	O
and	O
that	O
uneven	O
X	O
inactivation	O
is	O
the	O
underlying	O
mechanism	O
for	O
disease	O
expression	O
in	O
this	O
novel	O
female	O
MZ	O
twin	O
pair	O
.	O

This	O
is	O
the	O
first	O
documented	O
case	O
of	O
female	O
twins	O
discordant	O
for	O
Fabry	O
disease	O
.	O

682	NULL
CJF	NULL
INSERM	NULL
9206	NULL
,	NULL
Laboratoire	NULL
de	NULL
Biochimie	NULL
Médicale	NULL
,	NULL
``	NULL
Maladies	NULL
Métaboliques	NULL
``	NULL
,	NULL
Institut	NULL
Louis	NULL
Bugnard	NULL
,	NULL
Bitiment	NULL
L3	NULL
,	NULL
CHU	NULL
Rangueil	NULL
,	NULL
1	NULL
avenue	NULL
Jean	NULL
Poulhés	NULL
,	NULL
F-31054	NULL
Toulouse	NULL
Cedex	NULL
,	NULL
France	NULL
I	NULL
Redonnet-Vernhet	NULL
R	NULL
Salvayre	NULL
T	NULL
Levade	NULL
DNA	NULL
Laboratory	NULL
,	NULL
Clinical	NULL
Genetics	NULL
Centre	NULL
Utrecht	NULL
,	NULL
PO	NULL
Box	NULL
18009	NULL
,	NULL
3501	NULL
CA	NULL
Utrecht	NULL
,	NULL
The	NULL
Netherlands	NULL
J	NULL
K	NULL
Ploos	NULL
van	NULL
Amstel	NULL
R	NULL
P	NULL
M	NULL
Jansen	NULL
Laboratory	NULL
for	NULL
Neurology	NULL
and	NULL
Paediatrics	NULL
,	NULL
Institute	NULL
of	NULL
Neurology	NULL
,	NULL
Nijmegen	NULL
,	NULL
The	NULL
Netherlands	NULL
R	NULL
A	NULL
Wevers	NULL
Correspondence	NULL
to	NULL
:	NULL
Dr	NULL
Levade	NULL
.	NULL

Received	NULL
27	NULL
February	NULL
1996	NULL
Revised	NULL
version	NULL
accepted	NULL
for	NULL
publication	NULL
17	NULL
April	NULL
1996	NULL
J	NULL
Med	NULL
Genet	NULL
1996	NULL
;	NULL
33:682-688	NULL
Uneven	NULL
X	NULL
inactivation	NULL
in	NULL
a	NULL
female	NULL
monozygotic	NULL
twin	NULL
pair	NULL
with	NULL
Fabry	NULL
disease	NULL
and	NULL
discordant	NULL
expression	NULL
of	NULL
a	NULL
novel	NULL
mutation	NULL
in	NULL
the	NULL
-galactosidase	NULL
A	NULL
gene	NULL
I	NULL
Redonnet-Vernhet	NULL
,	NULL
J	NULL
K	NULL
Ploos	NULL
van	NULL
Amstel	NULL
,	NULL
R	NULL
P	NULL
M	NULL
Jansen	NULL
,	NULL
R	NULL
A	NULL
Wevers	NULL
,	NULL
R	NULL
Salvayre	NULL
,	NULL
T	NULL
Levade	NULL
Abstract	NULL
We	NULL
describe	NULL
two	NULL
female	NULL
monozygotic	NULL
(	NULL
MZ	NULL
)	NULL
twins	NULL
heterozygous	NULL
for	NULL
Fabry	NULL
disease	NULL
,	NULL
an	NULL
X	NULL
linked	NULL
disorder	NULL
resulting	NULL
from	NULL
the	NULL
deficient	NULL
activity	NULL
of	NULL
o-galactosidase	NULL
A	NULL
.	NULL

While	NULL
one	NULL
of	NULL
the	NULL
twins	NULL
was	NULL
clinically	NULL
affected	NULL
,	NULL
the	NULL
other	NULL
was	NULL
asymptomatic	NULL
.	NULL

Enzymatic	NULL
assay	NULL
of	NULL
o-galactosidase	NULL
in	NULL
blood	NULL
-	NULL
leucocytes	NULL
,	NULL
-	NULL
skin	NULL
-	NULL
fibroblasts	NULL
,	NULL
Epstein-Barr	NULL
virus	NULL
transformed	NULL
lymphoid	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
hair	NULL
follicles	NULL
of	NULL
the	NULL
twins	NULL
and	NULL
their	NULL
parents	NULL
confirmed	NULL
the	NULL
heterozygous	NULL
status	NULL
of	NULL
the	NULL
twins	NULL
and	NULL
indicated	NULL
that	NULL
Fabry	NULL
disease	NULL
had	NULL
occurred	NULL
as	NULL
a	NULL
result	NULL
of	NULL
a	NULL
de	NULL
novo	NULL
mutation	NULL
.	NULL

The	NULL
son	NULL
of	NULL
the	NULL
unaffected	NULL
twin	NULL
sister	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
hemizygous	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
«	NULL
-galactosidase	NULL
A	NULL
gene	NULL
permitted	NULL
the	NULL
identification	NULL
of	NULL
an	NULL
as	NULL
yet	NULL
undescribed	NULL
point	NULL
mutation	NULL
at	NULL
position	NULL
10182	NULL
of	NULL
exon	NULL
5	NULL
which	NULL
causes	NULL
an	NULL
Asp	NULL
to	NULL
Asn	NULL
substitution	NULL
at	NULL
codon	NULL
231	NULL
.	NULL

Single	NULL
strand	NULL
conformation	NULL
polymorphism	NULL
(	NULL
SSCP	NULL
)	NULL
analysis	NULL
again	NULL
showed	NULL
the	NULL
heterozygous	NULL
status	NULL
of	NULL
the	NULL
twins	NULL
and	NULL
a	NULL
normal	NULL
pattern	NULL
in	NULL
their	NULL
parents	NULL
.	NULL

The	NULL
basis	NULL
for	NULL
the	NULL
discordant	NULL
expression	NULL
of	NULL
this	NULL
de	NULL
novo	NULL
mutation	NULL
in	NULL
the	NULL
twins	NULL
was	NULL
investigated	NULL
by	NULL
studying	NULL
their	NULL
X	NULL
inactivation	NULL
status	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
inactive	NULL
X	NULL
specific	NULL
methylation	NULL
at	NULL
the	NULL
androgen	NULL
receptor	NULL
gene	NULL
showed	NULL
unbalanced	NULL
inactivation	NULL
in	NULL
the	NULL
twins	NULL
'	NULL
fibroblasts	NULL
and	NULL
in	NULL
opposite	NULL
directions	NULL
.	NULL

While	NULL
the	NULL
maternally	NULL
derived	NULL
X	NULL
chromosome	NULL
was	NULL
preferentially	NULL
active	NULL
in	NULL
the	NULL
asymptomatic	NULL
twin	NULL
,	NULL
the	NULL
paternal	NULL
X	NULL
chromosome	NULL
was	NULL
active	NULL
in	NULL
the	NULL
other	NULL
,	NULL
affected	NULL
twin	NULL
and	NULL
was	NULL
found	NULL
in	NULL
her	NULL
hemizygotic	NULL
nephew	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
paternal	NULL
X	NULL
chromosome	NULL
carries	NULL
the	NULL
de	NULL
novo	NULL
o-galactosidase	NULL
A	NULL
mutation	NULL
and	NULL
that	NULL
uneven	NULL
X	NULL
inactivation	NULL
is	NULL
the	NULL
underlying	NULL
mechanism	NULL
for	NULL
disease	NULL
expression	NULL
in	NULL
this	NULL
novel	NULL
female	NULL
MZ	NULL
twin	NULL
pair	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
documented	NULL
case	NULL
of	NULL
female	NULL
twins	NULL
discordant	NULL
for	NULL
Fabry	NULL
disease	NULL
.	NULL

(	NULL
J	NULL
Med	NULL
Genet	NULL
1996	NULL
;	NULL
331:682-688	NULL
)	NULL
Key	NULL
words	NULL
:	NULL
Fabry	NULL
disease	NULL
;	NULL
X	NULL
inactivation	NULL
;	NULL
monozygotic	NULL
twins	NULL
.	NULL

In	NULL
female	NULL
mammals	NULL
,	NULL
compensation	NULL
for	NULL
sex	NULL
differences	NULL
in	NULL
the	NULL
dosage	NULL
of	NULL
most	NULL
X	NULL
chromosomal	NULL
genes	NULL
occurs	NULL
during	NULL
early	NULL
embryogenesis	NULL
through	NULL
X	NULL
inactivation	NULL
.	NULL
'	NULL

''	NULL
This	NULL
phenomenon	NULL
results	NULL
in	NULL
selective	NULL
,	NULL
irreversible	NULL
inactivation	NULL
of	NULL
either	NULL
the	NULL
maternal	NULL
or	NULL
the	NULL
paternal	NULL
X	NULL
chromosome	NULL
of	NULL
each	NULL
somatic	NULL
cell	NULL
.	NULL

Since	NULL
X	NULL
inactivation	NULL
occurs	NULL
at	NULL
random	NULL
and	NULL
is	NULL
maintained	NULL
in	NULL
all	NULL
daughter	NULL
cells	NULL
,	NULL
females	NULL
exhibit	NULL
a	NULL
mosaic	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
X	NULL
linked	NULL
genes	NULL
,	NULL
each	NULL
X	NULL
chromosome	NULL
being	NULL
active	NULL
in	NULL
about	NULL
half	NULL
of	NULL
all	NULL
somatic	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
if	NULL
one	NULL
X	NULL
chromosome	NULL
is	NULL
predominantly	NULL
inactivated	NULL
in	NULL
a	NULL
female	NULL
heterozygous	NULL
for	NULL
an	NULL
X	NULL
linked	NULL
trait	NULL
,	NULL
this	NULL
may	NULL
lead	NULL
to	NULL
severe	NULL
manifestation	NULL
of	NULL
the	NULL
X	NULL
linked	NULL
disorder	NULL
.	NULL

Such	NULL
a	NULL
situation	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
female	NULL
monozygotic	NULL
(	NULL
MZ	NULL
)	NULL
twins	NULL
who	NULL
are	NULL
heterozygous	NULL
for	NULL
an	NULL
X	NULL
linked	NULL
disorder	NULL
.	NULL

In	NULL
all	NULL
the	NULL
pairs	NULL
(	NULL
22	NULL
)	NULL
of	NULL
heterozygous	NULL
identical	NULL
female	NULL
twins	NULL
published	NULL
so	NULL
far	NULL
,	NULL
``	NULL
there	NULL
was	NULL
discordant	NULL
expression	NULL
of	NULL
the	NULL
disease	NULL
,	NULL
that	NULL
is	NULL
,	NULL
only	NULL
one	NULL
twin	NULL
was	NULL
clinically	NULL
affected	NULL
,	NULL
which	NULL
is	NULL
interpreted	NULL
as	NULL
the	NULL
consequence	NULL
of	NULL
skewed	NULL
X	NULL
inactivation	NULL
in	NULL
opposite	NULL
directions	NULL
in	NULL
each	NULL
of	NULL
the	NULL
MZ	NULL
twins	NULL
.	NULL

Since	NULL
expression	NULL
of	NULL
an	NULL
X	NULL
linked	NULL
disorder	NULL
in	NULL
both	NULL
female	NULL
twins	NULL
has	NULL
never	NULL
been	NULL
described	NULL
,	NULL
an	NULL
interrelation	NULL
between	NULL
twinning	NULL
and	NULL
X	NULL
inactivation	NULL
has	NULL
been	NULL
postulated	NULL
.	NULL

*	NULL
``	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
report	NULL
the	NULL
occurrence	NULL
of	NULL
female	NULL
MZ	NULL
twins	NULL
with	NULL
discordant	NULL
expression	NULL
of	NULL
Fabry	NULL
disease	NULL
.	NULL

Anderson-Fabry	NULL
disease	NULL
(	NULL
MIM	NULL
301500	NULL
)	NULL
is	NULL
an	NULL
X	NULL
linked	NULL
disorder	NULL
caused	NULL
by	NULL
the	NULL
deficient	NULL
activity	NULL
of	NULL
the	NULL
lysosomal	NULL
exoglycohy-drolase	NULL
,	NULL
«	NULL
-galactosidase	NULL
A	NULL
(	NULL
EC	NULL
3.2.1.22	NULL
)	NULL
.	NULL
``	NULL

The	NULL
gene	NULL
encoding	NULL
-galactosidase	NULL
A	NULL
,	NULL
which	NULL
contains	NULL
seven	NULL
exons	NULL
and	NULL
extends	NULL
over	NULL
12	NULL
kb	NULL
,	NULL
is	NULL
localised	NULL
on	NULL
the	NULL
long	NULL
arm	NULL
of	NULL
the	NULL
X	NULL
chromosome	NULL
-	NULL
(	NULL
Xq22	NULL
)	NULL
.	NULL
``	NULL

``	NULL
~	NULL
In	NULL
-	NULL
addition	NULL
,	NULL
-	NULL
the	NULL
«	NULL
-galactosidase	NULL
A	NULL
gene	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
affected	NULL
by	NULL
X	NULL
inactivation	NULL
.	NULL
``	NULL

Loss	NULL
of	NULL
this	NULL
enzyme	NULL
activity	NULL
results	NULL
in	NULL
the	NULL
progressive	NULL
lysosomal	NULL
storage	NULL
of	NULL
glycosphingolipids	NULL
with	NULL
terminal	NULL
-	NULL
o-galactose	NULL
-	NULL
residues	NULL
.	NULL

-	NULL
Affected	NULL
hemizygous	NULL
males	NULL
accumulate	NULL
mainly	NULL
globo-triosylceramide	NULL
and	NULL
galabiosylceramide	NULL
within	NULL
the	NULL
vascular	NULL
endothelium	NULL
.	NULL

Clinical	NULL
manifestations	NULL
include	NULL
angiokeratoma	NULL
,	NULL
pain	NULL
in	NULL
the	NULL
extremities	NULL
,	NULL
corneal	NULL
opacities	NULL
,	NULL
renal	NULL
failure	NULL
,	NULL
and	NULL
vascular	NULL
disease	NULL
of	NULL
the	NULL
heart	NULL
and	NULL
brain	NULL
.	NULL

Most	NULL
heterozygous	NULL
females	NULL
are	NULL
clinically	NULL
asymptomatic	NULL
or	NULL
have	NULL
minimal	NULL
symptoms	NULL
(	NULL
the	NULL
most	NULL
frequent	NULL
being	NULL
characteristic	NULL
keratopathy	NULL
)	NULL
,	NULL
although	NULL
some	NULL
heterozygotes	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
as	NULL
severely	NULL
affected	NULL
as	NULL
hemizygous	NULL
males	NULL
.	NULL
``	NULL

While	NULL
Fabry	NULL
disease	NULL
in	NULL
males	NULL
can	NULL
be	NULL
definitively	NULL
diagnosed	NULL
by	NULL
demonstration	NULL
of	NULL
Discordant	NULL
expression	NULL
of	NULL
Fabry	NULL
disease	NULL
in	NULL
MZ	NULL
twins	NULL
Table	NULL
1	NULL
_	NULL
Short	NULL
tandem	NULL
repeat	NULL
(	NULL
STR	NULL
)	NULL
analysis	NULL
of	NULL
the	NULL
twin	NULL
sisters	NULL
Patient	NULL
Chromosome	NULL
STR	NULL
locus	NULL
location	NULL
I1	NULL
1.2	NULL
11.2	NULL
11.3	NULL
HPRT	NULL
Xq26	NULL
283	NULL
287	NULL
;	NULL
287	NULL
283	NULL
;	NULL
287	NULL
283	NULL
;	NULL
287	NULL
FABP2	NULL
4q28-q31	NULL
206	NULL
;	NULL
206	NULL
215	NULL
;	NULL
218	NULL
206	NULL
;	NULL
215	NULL
206	NULL
;	NULL
215	NULL
CSFIR	NULL
5q33-q34	NULL
308	NULL
;	NULL
308	NULL
308	NULL
;	NULL
312	NULL
308	NULL
;	NULL
308	NULL
308	NULL
;	NULL
308	NULL
TH	NULL
11p15.5	NULL
183	NULL
;	NULL
193	NULL
199	NULL
;	NULL
199	NULL
193	NULL
;	NULL
199	NULL
193	NULL
;	NULL
199	NULL
PLAZA	NULL
12q23-qter	NULL
121	NULL
;	NULL
127	NULL
119	NULL
;	NULL
121	NULL
121	NULL
;	NULL
127	NULL
121	NULL
;	NULL
127	NULL
F13A1	NULL
6p24-p25	NULL
281	NULL
;	NULL
293	NULL
290	NULL
;	NULL
290	NULL
290	NULL
;	NULL
293	NULL
290	NULL
;	NULL
293	NULL
CYP19	NULL
15q21.1	NULL
175	NULL
;	NULL
175	NULL
175	NULL
;	NULL
175	NULL
175	NULL
;	NULL
175	NULL
175	NULL
;	NULL
175	NULL
LPL	NULL
8p22	NULL
124	NULL
;	NULL
124	NULL
120	NULL
;	NULL
128	NULL
124	NULL
;	NULL
128	NULL
124	NULL
;	NULL
128	NULL
FES	NULL
15q25-qter	NULL
143	NULL
;	NULL
151	NULL
147	NULL
;	NULL
155	NULL
147	NULL
;	NULL
151	NULL
147	NULL
;	NULL
151	NULL
VWF	NULL
12p13	NULL
166	NULL
;	NULL
170	NULL
154	NULL
;	NULL
162	NULL
162	NULL
;	NULL
166	NULL
162	NULL
;	NULL
166	NULL
Allele	NULL
identification	NULL
was	NULL
achieved	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Methods	NULL
section	NULL
.	NULL

For	NULL
each	NULL
member	NULL
of	NULL
the	NULL
family	NULL
,	NULL
the	NULL
length	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
is	NULL
given	NULL
(	NULL
in	NULL
bp	NULL
)	NULL
.	NULL

STR	NULL
loci	NULL
are	NULL
named	NULL
according	NULL
to	NULL
the	NULL
Genome	NULL
Database	NULL
designation	NULL
,	NULL
as	NULL
reported	NULL
in	NULL
reference	NULL
24	NULL
.	NULL

The	NULL
Genome	NULL
Database	NULL
designations	NULL
of	NULL
FES	NULL
and	NULL
VWF	NULL
are	NULL
GO0-156-258	NULL
and	NULL
GO0-155-481	NULL
,	NULL
respectively	NULL
.	NULL

deficient	NULL
-galactosidase	NULL
A	NULL
activity	NULL
,	NULL
enzymatic	NULL
identification	NULL
of	NULL
female	NULL
carriers	NULL
is	NULL
often	NULL
inconclusive	NULL
because	NULL
of	NULL
the	NULL
very	NULL
wide	NULL
range	NULL
of	NULL
-galactosidase	NULL
A	NULL
activity	NULL
levels	NULL
owing	NULL
to	NULL
the	NULL
random	NULL
X	NULL
chromosomal	NULL
inactivation	NULL
phenom-enon	NULL
.	NULL

We	NULL
report	NULL
here	NULL
for	NULL
the	NULL
first	NULL
time	NULL
the	NULL
enzymatic	NULL
and	NULL
molecular	NULL
identification	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
characterisation	NULL
of	NULL
the	NULL
X	NULL
inactivation	NULL
status	NULL
,	NULL
of	NULL
female	NULL
MZ	NULL
twins	NULL
discordant	NULL
for	NULL
Fabry	NULL
disease	NULL
.	NULL

Family	NULL
history	NULL
The	NULL
clinical	NULL
and	NULL
pathological	NULL
features	NULL
of	NULL
this	NULL
Fabry	NULL
disease	NULL
family	NULL
have	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
elsewere	NULL
.	NULL
'	NULL

''	NULL
``	NULL
Briefly	NULL
,	NULL
a	NULL
26	NULL
year	NULL
old	NULL
woman	NULL
(	NULL
patient	NULL
IL2	NULL
,	NULL
fig	NULL
1	NULL
)	NULL
was	NULL
investigated	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
angiokeratomas	NULL
,	NULL
with	NULL
the	NULL
characteristic	NULL
``	NULL
swimsuit	NULL
``	NULL
distribution	NULL
.	NULL

The	NULL
history	NULL
indicated	NULL
the	NULL
onset	NULL
of	NULL
symptoms	NULL
at	NULL
the	NULL
age	NULL
of	NULL
16	NULL
years	NULL
,	NULL
with	NULL
a	NULL
progressive	NULL
course	NULL
including	NULL
acroparaes-thesia	NULL
in	NULL
all	NULL
four	NULL
limbs	NULL
.	NULL

Further	NULL
evaluation	NULL
of	NULL
the	NULL
patient	NULL
showed	NULL
isolated	NULL
proteinuria	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
verticillate	NULL
cornea	NULL
and	NULL
vascular	NULL
tortuosities	NULL
on	NULL
optic	NULL
fundus	NULL
examination	NULL
.	NULL

Electron	NULL
microscopy	NULL
of	NULL
the	NULL
skin	NULL
and	NULL
renal	NULL
biopsies	NULL
showed	NULL
the	NULL
typical	NULL
pattern	NULL
of	NULL
concentric	NULL
,	NULL
lamellar	NULL
inclusions	NULL
and	NULL
thin	NULL
layer	NULL
chromato-graphic	NULL
analysis	NULL
of	NULL
the	NULL
urine	NULL
showed	NULL
large	NULL
amounts	NULL
of	NULL
tri-	NULL
and	NULL
dihexosylceramide	NULL
.	NULL

The	NULL
twin	NULL
sister	NULL
(	NULL
II.3	NULL
)	NULL
showed	NULL
no	NULL
skin	NULL
lesions	NULL
.	NULL

No	NULL
verticillate	NULL
cornea	NULL
was	NULL
found	NULL
and	NULL
there	NULL
was	NULL
no	NULL
history	NULL
of	NULL
acroparaesthesia	NULL
.	NULL

Only	NULL
some	NULL
vacuolated	NULL
endothelial	NULL
cells	NULL
in	NULL
a	NULL
skin	NULL
biopsy	NULL
and	NULL
trace	NULL
amounts	NULL
of	NULL
trihexosylceramide	NULL
were	NULL
found	NULL
.	NULL
'	NULL

''	NULL
Monozygosity	NULL
was	NULL
strongly	NULL
suspected	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
physical	NULL
similarities	NULL
,	NULL
finger	NULL
prints	NULL
,	NULL
and	NULL
identity	NULL
of	NULL
erythrocyte	NULL
and	NULL
HLA	NULL
groups	NULL
.	NULL
``	NULL

Screening	NULL
of	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
family	NULL
indicated	NULL
that	NULL
the	NULL
son	NULL
of	NULL
the	NULL
unaffected	NULL
twin	NULL
(	NULL
patient	NULL
III.2	NULL
)	NULL
was	NULL
hemizygous	NULL
.	NULL

Figure	NULL
1	NULL
-	NULL
Pedigree	NULL
of	NULL
the	NULL
Fabry	NULL
disease	NULL
family	NULL
.	NULL

II	NULL
.	NULL

2	NULL
(	NULL
arrow	NULL
)	NULL
is	NULL
the	NULL
twin	NULL
manifesting	NULL
Fabry	NULL
disease	NULL
.	NULL

683	NULL
Methods	NULL
ISOLATION	NULL
OF	NULL
CELLS	NULL
AND	NULL
CELL	NULL
CULTURE	NULL
Tissue	NULL
samples	NULL
were	NULL
obtained	NULL
from	NULL
subjects	NULL
with	NULL
informed	NULL
consent	NULL
.	NULL

Leucocytes	NULL
from	NULL
heparinised	NULL
blood	NULL
were	NULL
isolated	NULL
``	NULL
using	NULL
Plas-magel®	NULL
(	NULL
Roger	NULL
Bellon	NULL
Lab	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Skin	NULL
fibroblasts	NULL
were	NULL
obtained	NULL
from	NULL
forearm	NULL
skin	NULL
biopsies	NULL
.	NULL

Lymphoid	NULL
cell	NULL
lines	NULL
were	NULL
established	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
transformation	NULL
of	NULL
blood	NULL
B	NULL
lymphocytes	NULL
obtained	NULL
from	NULL
controls	NULL
and	NULL
from	NULL
our	NULL
patients	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
10	NULL
ml	NULL
heparinised	NULL
blood	NULL
on	NULL
Ficoll-Histopaque	NULL
``	NULL
®	NULL
(	NULL
Sigma	NULL
,	NULL
L'Isle	NULL
d'Abeau	NULL
Chesnes	NULL
,	NULL
France	NULL
)	NULL
gradient	NULL
and	NULL
,	NULL
after	NULL
washing	NULL
,	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
Epstein-Barr	NULL
virus	NULL
B95-8	NULL
strain	NULL
.	NULL
``	NULL

After	NULL
24	NULL
hours	NULL
'	NULL
incubation	NULL
,	NULL
half	NULL
of	NULL
this	NULL
medium	NULL
was	NULL
replaced	NULL
by	NULL
fresh	NULL
medium	NULL
supplemented	NULL
with	NULL
cyclosporin	NULL
A	NULL
and	NULL
the	NULL
culture	NULL
was	NULL
continued	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Lymphoid	NULL
cells	NULL
and	NULL
skin	NULL
fibroblasts	NULL
were	NULL
grown	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
atmosphere	NULL
at	NULL
37°C	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
-	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
-	NULL
Cergy-Pontoise	NULL
,	NULL
France	NULL
)	NULL
supplemented	NULL
with	NULL
L-glutamine	NULL
(	NULL
2	NULL
mmol/l	NULL
}	NULL
,	NULL
penicillin	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
streptomycin	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
heat	NULL
inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
10	NULL
%	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
harvested	NULL
by	NULL
slow	NULL
speed	NULL
centrifugation	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
.	NULL

Cell	NULL
pellets	NULL
were	NULL
kept	NULL
frozen	NULL
at	NULL
-70°C	NULL
until	NULL
use	NULL
.	NULL

ENZYME	NULL
STUDIES	NULL
«	NULL
-Galactosidase	NULL
activity	NULL
was	NULL
assayed	NULL
in	NULL
extracts	NULL
of	NULL
peripheral	NULL
blood	NULL
leucocytes	NULL
,	NULL
cultured	NULL
skin	NULL
fibroblasts	NULL
,	NULL
and	NULL
Epstein-Barr	NULL
virus	NULL
transformed	NULL
lymphoid	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4A-methylumbelliferyl-a-D-galactopyranoside	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

«	NULL
-Galactosidase	NULL
A	NULL
activity	NULL
was	NULL
specifically	NULL
determined	NULL
``	NULL
using	NULL
heat	NULL
stability	NULL
assays	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
(	NULL
-N-acetylgalactosamine	NULL
.	NULL

«	NULL
-Galactosidase	NULL
activity	NULL
was	NULL
also	NULL
measured	NULL
on	NULL
single	NULL
hair	NULL
roots	NULL
as	NULL
previously	NULL
reported	NULL
``	NULL
``	NULL
;	NULL
hair	NULL
root	NULL
activities	NULL
were	NULL
expressed	NULL
as	NULL
a	NULL
ratio	NULL
of	NULL
o-galactosidase/B-hexosaminidase	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
B-hexosaminidase	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

``	NULL
*	NULL
DNA	NULL
ANALYSES	NULL
Preparation	NULL
of	NULL
genomic	NULL
DNA	NULL
Fibroblast	NULL
and	NULL
lymphoid	NULL
cell	NULL
pellets	NULL
were	NULL
suspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mmol/l	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
100	NULL
mmol/l	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/l	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
)	NULL
with	NULL
proteinase	NULL
K	NULL
(	NULL
200	NULL
ug/ml	NULL
)	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
56°C	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
extracted	NULL
with	NULL
phenol-chloroform	NULL
(	NULL
two	NULL
cycles	NULL
)	NULL
,	NULL
precipitated	NULL
with	NULL
ethanol	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
deionised	NULL
water	NULL
for	NULL
amplification	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
.	NULL
``	NULL

Polymorphism	NULL
studies	NULL
The	NULL
twin	NULL
sisters	NULL
and	NULL
their	NULL
parents	NULL
were	NULL
tested	NULL
for	NULL
zygosity	NULL
by	NULL
short	NULL
tandem	NULL
repeats	NULL
(	NULL
STR	NULL
)	NULL
loci	NULL
PCR	NULL
analysis	NULL
as	NULL
previously	NULL
reported	NULL
``	NULL
(	NULL
table	NULL
1	NULL
)	NULL
using	NULL
the	NULL
ALF	NULL
Fragment	NULL
Manager	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

«	NULL
-Galactosidase	NULL
A	NULL
DNA	NULL
amplification	NULL
The	NULL
seven	NULL
exons	NULL
encoding	NULL
-galactosidase	NULL
A	NULL
and	NULL
their	NULL
flanking	NULL
sequences	NULL
were	NULL
PCR	NULL
ampli-	NULL
684	NULL
Redonnet-Vernhet	NULL
,	NULL
Ploos	NULL
van	NULL
Amstel	NULL
,	NULL
Jansen	NULL
,	NULL
Wevers	NULL
,	NULL
Salvayre	NULL
,	NULL
Levade	NULL
Table	NULL
2	NULL
-	NULL
-Galactosidase	NULL
activity	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
members	NULL
of	NULL
the	NULL
affected	NULL
family	NULL
Patient	NULL
Enzyme	NULL
Cell	NULL
type	NULL
1.1	NULL
1.2	NULL
IL	NULL
.	NULL

1	NULL
11.2	NULL
IIL	NULL
.	NULL

1	NULL
IL	NULL
3	NULL
IIL	NULL
.	NULL

2	NULL
Controls	NULL
(	NULL
mean	NULL
(	NULL
SD	NULL
)	NULL
)	NULL
«	NULL
-Gal	NULL
Leucocytes	NULL
37	NULL
30.5	NULL
27	NULL
14	NULL
38	NULL
15	NULL
3.5	NULL
36	NULL
(	NULL
6	NULL
)	NULL
Fibroblasts	NULL
13	NULL
62	NULL
90	NULL
(	NULL
20	NULL
)	NULL
LCL	NULL
22.0	NULL
7.8	NULL
11.0	NULL
0.85	NULL
21.6	NULL
(	NULL
6.4	NULL
)	NULL
«	NULL
-Gal/f-Hex	NULL
_	NULL
Leucocytes	NULL
0.042	NULL
0.035	NULL
0.032	NULL
0.016	NULL
0.036	NULL
0.008	NULL
0.002	NULL
0.035	NULL
(	NULL
0.01	NULL
)	NULL
Fibroblasts	NULL
0.002	NULL
0.010	NULL
0.015	NULL
(	NULL
0.005	NULL
)	NULL
-Galactosidase	NULL
(	NULL
«	NULL
-Gal	NULL
)	NULL
and	NULL
total	NULL
B-hexosaminidase	NULL
(	NULL
B-Hex	NULL
)	NULL
activities	NULL
were	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
,	NULL
and	NULL
are	NULL
expressed	NULL
as	NULL
nmol	NULL
of	NULL
methylumbelliferone	NULL
released	NULL
per	NULL
hour	NULL
per	NULL
mg	NULL
of	NULL
cell	NULL
protein	NULL
.	NULL

LCL=lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

fied	NULL
using	NULL
previously	NULL
described	NULL
primers	NULL
.	NULL
``	NULL

The	NULL
amplification	NULL
was	NULL
performed	NULL
in	NULL
33	NULL
cycles	NULL
,	NULL
each	NULL
cycle	NULL
consisting	NULL
of	NULL
one	NULL
minute	NULL
denaturation	NULL
at	NULL
94°C	NULL
,	NULL
one	NULL
minute	NULL
annealing	NULL
at	NULL
55°C	NULL
,	NULL
and	NULL
two	NULL
minutes	NULL
extension	NULL
at	NULL
72°C	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
contained	NULL
400	NULL
ng	NULL
of	NULL
high	NULL
molecular	NULL
weight	NULL
DNA	NULL
,	NULL
400	NULL
ng	NULL
of	NULL
each	NULL
primer	NULL
,	NULL
200	NULL
umol/l	NULL
of	NULL
each	NULL
dNTP	NULL
,	NULL
100	NULL
ug/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
67	NULL
mmol/l	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
,	NULL
6.7	NULL
mmol/l	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mmol/l	NULL
B-mercaptoethanol	NULL
,	NULL
6.7	NULL
umo	NULL
!	NULL

/l	NULL
EDTA	NULL
,	NULL
16.6	NULL
mmol/l	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
,	NULL
S0O4	NULL
,	NULL
10	NULL
%	NULL
dimethylsulphoxide	NULL
,	NULL
and	NULL
40	NULL
U/ml	NULL
of	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
(	NULL
Cetus	NULL
Corp	NULL
,	NULL
Emeryville	NULL
,	NULL
CA	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
fragments	NULL
were	NULL
analysed	NULL
by	NULL
electrophoresis	NULL
on	NULL
2	NULL
%	NULL
agarose	NULL
gels	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
determination	NULL
The	NULL
amplified	NULL
DNA	NULL
was	NULL
purified	NULL
by	NULL
ultralow	NULL
gelling	NULL
temperature	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
excised	NULL
fragments	NULL
were	NULL
directly	NULL
sequenced	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
reaction	NULL
with	NULL
a	NULL
pUC	NULL
sequencing	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
using	NULL
[	NULL
«	NULL
-	NULL
(	NULL
600	NULL
Ci/mmol	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
primers	NULL
were	NULL
used	NULL
as	NULL
primers	NULL
in	NULL
the	NULL
sequencing	NULL
reaction	NULL
.	NULL

Single	NULL
strand	NULL
conformation	NULL
polymorphism	NULL
(	NULL
SSCP	NULL
)	NULL
SSCP	NULL
was	NULL
identified	NULL
by	NULL
automated	NULL
electrophoresis	NULL
on	NULL
12.5	NULL
%	NULL
homogeneous	NULL
PhastGels	NULL
(	NULL
Pharmacia-LKB	NULL
)	NULL
with	NULL
native	NULL
bufferstrips	NULL
for	NULL
200	NULL
Vh	NULL
at	NULL
4°C	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
visualised	NULL
by	NULL
silver	NULL
staining	NULL
.	NULL

Analysis	NULL
of	NULL
X	NULL
inactivation	NULL
patterns	NULL
The	NULL
X	NULL
inactivation	NULL
pattern	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
studying	NULL
the	NULL
methylation	NULL
of	NULL
the	NULL
Hhal	NULL
sites	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
locus	NULL
as	NULL
previously	NULL
reported	NULL
.	NULL
``	NULL

DNA	NULL
samples	NULL
(	NULL
1	NULL
ug	NULL
,	NULL
20	NULL
pul	NULL
)	NULL
were	NULL
digested	NULL
with	NULL
20	NULL
U	NULL
of	NULL
Hkal	NULL
(	NULL
Gibco	NULL
BRL	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
or	NULL
incubated	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
without	NULL
enzyme	NULL
,	NULL
for	NULL
10	NULL
hours	NULL
at	NULL
37°C	NULL
.	NULL

Ten	NULL
microlitre	NULL
aliquots	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
{	NULL
100	NULL
ul	NULL
final	NULL
volume	NULL
)	NULL
with	NULL
0.5	NULL
umol/l	NULL
of	NULL
each	NULL
primer	NULL
(	NULL
synthesised	NULL
by	NULL
Eurogentec	NULL
,	NULL
Seraing	NULL
,	NULL
Belgium	NULL
)	NULL
,	NULL
200	NULL
umol/l	NULL
dNTPs	NULL
,	NULL
2.5	NULL
U	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
(	NULL
Eurobio	NULL
,	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
,	NULL
10	NULL
mmol/l	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
9	NULL
)	NULL
,	NULL
50	NULL
mmol/l	NULL
KCl	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
2.5	NULL
mmol/l	NULL
MgCl	NULL
;	NULL
.	NULL

Samples	NULL
were	NULL
amplified	NULL
using	NULL
a	NULL
TRIO-Thermoblock	NULL
(	NULL
Biometra	NULL
,	NULL
Gottingen	NULL
,	NULL
Ger-many	NULL
)	NULL
for	NULL
35	NULL
cycles	NULL
,	NULL
each	NULL
consisting	NULL
of	NULL
a	NULL
denaturing	NULL
step	NULL
at	NULL
95°C	NULL
for	NULL
one	NULL
minute	NULL
,	NULL
an	NULL
annealing	NULL
step	NULL
at	NULL
60°C	NULL
for	NULL
30	NULL
seconds	NULL
,	NULL
and	NULL
an	NULL
extension	NULL
step	NULL
at	NULL
72°C	NULL
for	NULL
30	NULL
seconds	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
analysed	NULL
on	NULL
a	NULL
12	NULL
%	NULL
polyacrylamide	NULL
(	NULL
29:1	NULL
)	NULL
non-denaturing	NULL
gel	NULL
.	NULL

Relative	NULL
intensity	NULL
of	NULL
bands	NULL
after	NULL
ethidium	NULL
bromide	NULL
staining	NULL
was	NULL
assessed	NULL
by	NULL
densitometry	NULL
using	NULL
a	NULL
Biocom	NULL
scan	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
amplified	NULL
fragments	NULL
averaged	NULL
280	NULL
bp	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
11-31	NULL
CAG	NULL
repeat	NULL
units	NULL
.	NULL
``	NULL

Results	NULL
CYTOGENETIC	NULL
AND	NULL
POLYMORPHISM	NULL
STUDIES	NULL
Cytogenetic	NULL
analysis	NULL
showed	NULL
normal	NULL
karyo-types	NULL
in	NULL
both	NULL
twins	NULL
.	NULL

The	NULL
sisters	NULL
shared	NULL
the	NULL
same	NULL
alleles	NULL
for	NULL
all	NULL
STR	NULL
markers	NULL
tested	NULL
.	NULL

Product	NULL
length	NULL
of	NULL
each	NULL
marker	NULL
is	NULL
shown	NULL
in	NULL
table	NULL
1	NULL
for	NULL
both	NULL
parents	NULL
and	NULL
the	NULL
sisters	NULL
.	NULL

The	NULL
PLAZA	NULL
,	NULL
VWF	NULL
,	NULL
and	NULL
FES	NULL
markers	NULL
were	NULL
informative	NULL
for	NULL
both	NULL
parents	NULL
,	NULL
the	NULL
CYP19	NULL
marker	NULL
was	NULL
not	NULL
informative	NULL
,	NULL
and	NULL
the	NULL
other	NULL
six	NULL
markers	NULL
were	NULL
informative	NULL
for	NULL
a	NULL
single	NULL
parent	NULL
.	NULL

From	NULL
these	NULL
data	NULL
ft	NULL
can	NULL
be	NULL
calculated	NULL
that	NULL
the	NULL
sisters	NULL
II.2	NULL
and	NULL
II.3	NULL
are	NULL
monozygotic	NULL
twins	NULL
with	NULL
a	NULL
probability	NULL
of	NULL
99.98	NULL
%	NULL
.	NULL

(	NULL
-GALACTOSIDASE	NULL
ENZYME	NULL
STUDIES	NULL
As	NULL
illustrated	NULL
in	NULL
table	NULL
2	NULL
,	NULL
both	NULL
the	NULL
clinically	NULL
affected	NULL
woman	NULL
(	NULL
patient	NULL
II.2	NULL
)	NULL
and	NULL
her	NULL
clinically	NULL
unaffected	NULL
MZ	NULL
twin	NULL
sister	NULL
(	NULL
patient	NULL
II.3	NULL
)	NULL
exhibited	NULL
clearly	NULL
reduced	NULL
levels	NULL
of	NULL
-galactosidase	NULL
activity	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
,	NULL
indicating	NULL
their	NULL
heterozygous	NULL
status	NULL
for	NULL
the	NULL
Fabry	NULL
trait	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
non-manifesting	NULL
twin	NULL
was	NULL
indeed	NULL
a	NULL
carrier	NULL
for	NULL
Fabry	NULL
disease	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
her	NULL
son	NULL
(	NULL
IIL2	NULL
)	NULL
had	NULL
severe	NULL
(	NULL
-galactosidase	NULL
activity	NULL
deficiency	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
hemizygous	NULL
status	NULL
.	NULL

Normal	NULL
total	NULL
«	NULL
-galactosidase	NULL
and	NULL
-galactosidase	NULL
A	NULL
``	NULL
activities	NULL
were	NULL
found	NULL
in	NULL
both	NULL
the	NULL
mother	NULL
and	NULL
father	NULL
of	NULL
the	NULL
twins	NULL
(	NULL
table	NULL
2	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
other	NULL
members	NULL
of	NULL
this	NULL
family	NULL
.	NULL
``	NULL

The	NULL
heterozygous	NULL
status	NULL
of	NULL
the	NULL
twins	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
analysing	NULL
the	NULL
enzyme	NULL
activities	NULL
in	NULL
single	NULL
hair	NULL
follicles	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
fig	NULL
2	NULL
,	NULL
the	NULL
twin	NULL
sisters	NULL
had	NULL
some	NULL
hair	NULL
follicle	NULL
values	NULL
in	NULL
the	NULL
normal	NULL
range	NULL
(	NULL
fig	NULL
2	NULL
(	NULL
left	NULL
)	NULL
for	NULL
female	NULL
con-trols	NULL
)	NULL
but	NULL
also	NULL
values	NULL
distinctly	NULL
below	NULL
the	NULL
normal	NULL
range	NULL
,	NULL
that	NULL
is	NULL
,	NULL
in	NULL
the	NULL
range	NULL
of	NULL
the	NULL
hemizygous	NULL
son	NULL
(	NULL
III.2	NULL
)	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
further	NULL
evidence	NULL
for	NULL
the	NULL
heterozygous	NULL
status	NULL
of	NULL
the	NULL
twins	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
none	NULL
of	NULL
the	NULL
25	NULL
hair	NULL
roots	NULL
analysed	NULL
in	NULL
their	NULL
mother	NULL
(	NULL
1.2	NULL
)	NULL
showed	NULL
abnormal	NULL
(	NULL
intermediate	NULL
or	NULL
deficient	NULL
)	NULL
-galactosidase	NULL
activity	NULL
(	NULL
fig	NULL
2	NULL
,	NULL
right	NULL
)	NULL
.	NULL

The	NULL
enzymatic	NULL
data	NULL
therefore	NULL
suggest	NULL
that	NULL
Fabry	NULL
disease	NULL
in	NULL
the	NULL
twins	NULL
occurred	NULL
as	NULL
a	NULL
result	NULL
of	NULL
a	NULL
de	NULL
novo	NULL
mutation	NULL
.	NULL

(	NULL
-GALACTOSIDASE	NULL
A	NULL
MOLECULAR	NULL
STUDIES	NULL
The	NULL
seven	NULL
exons	NULL
of	NULL
the	NULL
-galactosidase	NULL
A	NULL
gene	NULL
of	NULL
the	NULL
proband	NULL
(	NULL
III.2	NULL
)	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
ampli-	NULL
Discordant	NULL
expression	NULL
of	NULL
Fabry	NULL
disease	NULL
in	NULL
MZ	NULL
twins	NULL
685	NULL
o	NULL
o	NULL
012	NULL
-	NULL
0-12	NULL
|-	NULL
e	NULL
&	NULL
010	NULL
|-	NULL
010	NULL
|-	NULL
o	NULL
©	NULL
B	NULL
bet	NULL
o	NULL
8	NULL
o	NULL
©	NULL
0-08	NULL
|-	NULL
e	NULL
0-08	NULL
|-	NULL
H	NULL
0	NULL
@	NULL
©	NULL
©	NULL
®	NULL
e	NULL
B	NULL
o	NULL
IC	NULL
06	NULL
|-	NULL
do	NULL
06	NULL
|-	NULL
e	NULL
I	NULL
-	NULL
o06	NULL
*	NULL
[	NULL
o	NULL
0-06	NULL
e	NULL
pe	NULL
=	NULL
e	NULL
LJ	NULL
[	NULL
]	NULL
3	NULL
'	NULL
©	NULL
e	NULL
8	NULL
04	NULL
|-	NULL
bo	NULL
04	NULL
|-0-04	NULL
M	NULL
y	NULL
0-0	NULL
pa	NULL
o	NULL
®	NULL
e	NULL
|	NULL
&	NULL
8	NULL
®	NULL
0-02	NULL
|-	NULL
0-02	NULL
|-0-00	NULL
--	NULL
e	NULL
0-00	NULL
in	NULL
|	NULL
|	NULL
cC1	NULL
~	NULL
cr	NULL
C30	NULL
C4	NULL
C50	NULL
C6	NULL
I2	NULL
I3	NULL
I12	NULL
12	NULL
Figure	NULL
2	NULL
-	NULL
-Galactosidase	NULL
activity	NULL
in	NULL
hair	NULL
follicles	NULL
from	NULL
control	NULL
female	NULL
subjects	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
members	NULL
of	NULL
the	NULL
present	NULL
Fabry	NULL
family	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
-galactosidase	NULL
(	NULL
@	NULL
-GAL	NULL
)	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Methods	NULL
section	NULL
and	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
ratio	NULL
to	NULL
B-hexosaminidase	NULL
(	NULL
B-HEX	NULL
)	NULL
activity	NULL
.	NULL

Each	NULL
point	NULL
corresponds	NULL
to	NULL
a	NULL
different	NULL
hair	NULL
root	NULL
.	NULL

fied	NULL
by	NULL
PCR	NULL
and	NULL
were	NULL
of	NULL
the	NULL
expected	NULL
size	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
if	NULL
the	NULL
gene	NULL
defect	NULL
of	NULL
the	NULL
proband	NULL
is	NULL
located	NULL
in	NULL
the	NULL
amplified	NULL
fragments	NULL
,	NULL
it	NULL
is	NULL
too	NULL
small	NULL
to	NULL
be	NULL
detected	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

We	NULL
then	NULL
determined	NULL
the	NULL
nucleotide	NULL
sequence	NULL
of	NULL
all	NULL
the	NULL
amplified	NULL
fragments	NULL
.	NULL

A	NULL
single	NULL
alteration	NULL
was	NULL
found	NULL
.	NULL

At	NULL
position	NULL
10182	NULL
of	NULL
exon	NULL
5	NULL
of	NULL
the	NULL
«	NULL
-galactosidase	NULL
A	NULL
gene	NULL
(	NULL
GenBank	NULL
accession	NULL
No	NULL
X14448	NULL
)	NULL
a	NULL
G	NULL
to	NULL
A	NULL
transition	NULL
has	NULL
occurred	NULL
(	NULL
fig	NULL
3	NULL
)	NULL
.	NULL

This	NULL
alteration	NULL
causes	NULL
an	NULL
Asp	NULL
to	NULL
Asn	NULL
amino	NULL
acid	NULL
substitution	NULL
at	NULL
codon	NULL
231	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

The	NULL
segregation	NULL
of	NULL
the	NULL
G10182A	NULL
mutation	NULL
was	NULL
followed	NULL
in	NULL
the	NULL
pedigree	NULL
by	NULL
SSCP	NULL
.	NULL

Fig	NULL
4	NULL
depicts	NULL
the	NULL
SSCP	NULL
analysis	NULL
of	NULL
the	NULL
G10182A	NULL
transition	NULL
.	NULL

The	NULL
proband	NULL
III.2	NULL
showed	NULL
a	NULL
mobility	NULL
shift	NULL
for	NULL
both	NULL
DNA	NULL
strands	NULL
of	NULL
the	NULL
exon	NULL
5	NULL
PCR	NULL
product	NULL
.	NULL

Both	NULL
his	NULL
mother	NULL
(	NULL
II.3	NULL
)	NULL
and	NULL
his	NULL
aunt	NULL
(	NULL
II.2	NULL
)	NULL
exhibited	NULL
the	NULL
normal	NULL
and	NULL
abnormal	NULL
patterns	NULL
,	NULL
showing	NULL
heterozygosity	NULL
for	NULL
the	NULL
abnor-mality	NULL
.	NULL

The	NULL
grandparents	NULL
(	NULL
I	NULL
.	NULL

1	NULL
and	NULL
1.2	NULL
)	NULL
had	NULL
the	NULL
normal	NULL
pattern	NULL
.	NULL

Since	NULL
neither	NULL
maternal	NULL
grandparent	NULL
(	NULL
I.1	NULL
or	NULL
1.2	NULL
)	NULL
had	NULL
the	NULL
mutant	NULL
allele	NULL
,	NULL
and	NULL
since	NULL
non-paternity	NULL
of	NULL
the	NULL
grandfather	NULL
was	NULL
unlikely	NULL
because	NULL
of	NULL
HLA	NULL
typing	NULL
``	NULL
and	NULL
polymorphism	NULL
-i	NULL
lle	NULL
231	NULL
Asn	NULL
Asp	NULL
P	NULL
P	NULL
O	NULL
p	NULL
<	NULL
O	NULL
4	NULL
Q	NULL
P	NULL
O	NULL
P	NULL
<	NULL
4	NULL
<	NULL
Ala	NULL
O	NULL
M	NULL
M	NULL
P	NULL
N	NULL
P	NULL
N	NULL
P	NULL
N	NULL
P	NULL
N	NULL
Figure	NULL
3	NULL
-	NULL
DNA	NULL
sequence	NULL
gel	NULL
showing	NULL
the	NULL
G10182A	NULL
mutation	NULL
.	NULL

The	NULL
G	NULL
,	NULL
A	NULL
,	NULL
T	NULL
,	NULL
and	NULL
C	NULL
reactions	NULL
of	NULL
the	NULL
proband	NULL
III	NULL
.	NULL

2	NULL
(	NULL
P	NULL
)	NULL
and	NULL
a	NULL
normal	NULL
control	NULL
(	NULL
N	NULL
)	NULL
have	NULL
been	NULL
loaded	NULL
alternately	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
point	NULL
mutation	NULL
.	NULL

studies	NULL
(	NULL
table	NULL
1	NULL
)	NULL
,	NULL
both	NULL
the	NULL
enzymatic	NULL
and	NULL
molecular	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
de	NULL
novo	NULL
mutation	NULL
.	NULL

ANALYSIS	NULL
OF	NULL
THE	NULL
X	NULL
INACTIVATION	NULL
PATTERN	NULL
Analysis	NULL
of	NULL
the	NULL
methylation	NULL
of	NULL
the	NULL
Hhal	NULL
sites	NULL
adjacent	NULL
to	NULL
the	NULL
highly	NULL
polymorphic	NULL
CAG	NULL
repeat	NULL
(	NULL
90	NULL
%	NULL
heterozygosity	NULL
)	NULL
of	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
gene	NULL
was	NULL
informative	NULL
and	NULL
was	NULL
performed	NULL
on	NULL
cultured	NULL
skin	NULL
fibroblasts	NULL
(	NULL
fig	NULL
5A	NULL
)	NULL
and	NULL
lymphoid	NULL
cells	NULL
(	NULL
fig	NULL
5B	NULL
)	NULL
from	NULL
the	NULL
twins	NULL
.	NULL

In	NULL
this	NULL
assay	NULL
,	NULL
DNA	NULL
is	NULL
digested	NULL
with	NULL
kal	NULL
before	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
polymorphic	NULL
repeat	NULL
.	NULL

Only	NULL
methylated	NULL
alleles	NULL
,	NULL
present	NULL
on	NULL
an	NULL
inactive	NULL
X	NULL
chromosome	NULL
,	NULL
can	NULL
be	NULL
amplified	NULL
.	NULL
``	NULL

This	NULL
semi-quantitative	NULL
method	NULL
allows	NULL
reliable	NULL
Figure	NULL
4	NULL
-	NULL
Single	NULL
strand	NULL
conformation	NULL
analysis	NULL
of	NULL
exon	NULL
5	NULL
of	NULL
the	NULL
-galactosidase	NULL
A	NULL
gene	NULL
.	NULL

The	NULL
gel	NULL
shows	NULL
a	NULL
mobility	NULL
shift	NULL
for	NULL
the	NULL
G10182A4	NULL
transition	NULL
that	NULL
results	NULL
in	NULL
a	NULL
D231N	NULL
amino	NULL
acid	NULL
substitution	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
shifted	NULL
bands	NULL
.	NULL

The	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
homogeneous	NULL
PhastGe	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Methods	NULL
section	NULL
.	NULL

TM	NULL
686	NULL
Redonnet-Vernhet	NULL
,	NULL
Ploos	NULL
van	NULL
Amstel	NULL
,	NULL
Jansen	NULL
,	NULL
Wevers	NULL
,	NULL
Salvayre	NULL
,	NULL
Levade	NULL
Hhal	NULL
t	NULL
+	NULL
4	NULL
+	NULL
Hhal	NULL
Figure	NULL
5	NULL
_	NULL
Study	NULL
of	NULL
X	NULL
inactivation	NULL
patterns	NULL
in	NULL
the	NULL
present	NULL
Fabry	NULL
family	NULL
by	NULL
using	NULL
analysis	NULL
of	NULL
methylation	NULL
of	NULL
Hhal	NULL
sites	NULL
at	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
locus	NULL
.	NULL

DNA	NULL
samples	NULL
from	NULL
cultured	NULL
skin	NULL
fibroblasts	NULL
and	NULL
lymphoid	NULL
cell	NULL
lines	NULL
of	NULL
the	NULL
patients	NULL
were	NULL
PCR	NULL
amplified	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
,	NULL
after	NULL
preincubation	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
+	NULL
)	NULL
)	NULL
of	NULL
Hhal	NULL
.	NULL

The	NULL
androgen	NULL
receptor	NULL
alleles	NULL
in	NULL
the	NULL
twins	NULL
'	NULL
fibroblasts	NULL
(	NULL
A	NULL
)	NULL
or	NULL
lymphoid	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
are	NULL
compared	NULL
to	NULL
those	NULL
of	NULL
the	NULL
lymphoid	NULL
cells	NULL
from	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
family	NULL
.	NULL

In	NULL
fibroblasts	NULL
,	NULL
densitometric	NULL
analysis	NULL
of	NULL
digested	NULL
alleles	NULL
indicated	NULL
ratios	NULL
of	NULL
0:100	NULL
and	NULL
97:3	NULL
for	NULL
the	NULL
paternal	NULL
:	NULL
maternal	NULL
alleles	NULL
in	NULL
the	NULL
affected	NULL
(	NULL
II	NULL
.	NULL

2	NULL
)	NULL
and	NULL
unaffected	NULL
(	NULL
II	NULL
.	NULL

3	NULL
)	NULL
twin	NULL
sisters	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
lymphoid	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
after	NULL
digestion	NULL
,	NULL
ratios	NULL
of	NULL
12:88	NULL
and	NULL
37:63	NULL
were	NULL
obtained	NULL
for	NULL
the	NULL
manifesting	NULL
and	NULL
unaffected	NULL
twins	NULL
,	NULL
respectively	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
five	NULL
to	NULL
10	NULL
separate	NULL
experiments	NULL
.	NULL

interpretation	NULL
of	NULL
the	NULL
X	NULL
inactivation	NULL
status	NULL
only	NULL
when	NULL
perfectly	NULL
random	NULL
or	NULL
almost	NULL
100	NULL
%	NULL
skewed	NULL
patterns	NULL
are	NULL
obtained	NULL
.	NULL
``	NULL

Fig	NULL
5A	NULL
shows	NULL
the	NULL
various	NULL
alleles	NULL
in	NULL
the	NULL
Fabry	NULL
twins	NULL
'	NULL
fibroblasts	NULL
.	NULL

PCR	NULL
without	NULL
previous	NULL
Hhal	NULL
digestion	NULL
was	NULL
also	NULL
performed	NULL
on	NULL
lymphoid	NULL
cells	NULL
from	NULL
the	NULL
parents	NULL
and	NULL
the	NULL
affected	NULL
child	NULL
.	NULL

The	NULL
alleles	NULL
in	NULL
the	NULL
undigested	NULL
samples	NULL
were	NULL
of	NULL
approximately	NULL
equal	NULL
intensity	NULL
.	NULL

Methylation	NULL
patterns	NULL
of	NULL
the	NULL
twins	NULL
were	NULL
determined	NULL
by	NULL
comparing	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
paternal	NULL
and	NULL
maternal	NULL
alleles	NULL
in	NULL
samples	NULL
that	NULL
had	NULL
been	NULL
digested	NULL
with	NULL
the	NULL
restriction	NULL
endonuclease	NULL
.	NULL

A	NULL
skewed	NULL
methylation	NULL
pattern	NULL
in	NULL
opposite	NULL
directions	NULL
was	NULL
apparent	NULL
in	NULL
the	NULL
fibroblast	NULL
DNA	NULL
samples	NULL
from	NULL
the	NULL
twins	NULL
(	NULL
fig	NULL
5A	NULL
)	NULL
.	NULL

In	NULL
one	NULL
twin	NULL
(	NULL
II.2	NULL
)	NULL
,	NULL
the	NULL
ratio	NULL
of	NULL
paternal	NULL
:	NULL
maternal	NULL
alleles	NULL
after	NULL
HhaI	NULL
digestion	NULL
was	NULL
0:100	NULL
while	NULL
this	NULL
ratio	NULL
was	NULL
97:3	NULL
in	NULL
the	NULL
other	NULL
twin	NULL
(	NULL
II.3	NULL
)	NULL
.	NULL

From	NULL
this	NULL
methylation	NULL
pattern	NULL
,	NULL
it	NULL
can	NULL
be	NULL
concluded	NULL
that	NULL
the	NULL
paternal	NULL
X	NULL
chromosome	NULL
is	NULL
preferentially	NULL
active	NULL
in	NULL
the	NULL
Fabry	NULL
diseased	NULL
twin	NULL
and	NULL
that	NULL
the	NULL
maternal	NULL
X	NULL
chromosome	NULL
is	NULL
active	NULL
in	NULL
the	NULL
unaffected	NULL
sister	NULL
.	NULL

Since	NULL
the	NULL
X	NULL
chromosome	NULL
active	NULL
in	NULL
the	NULL
affected	NULL
twin	NULL
(	NULL
IL.2	NULL
)	NULL
and	NULL
the	NULL
Fabry	NULL
hemizygote	NULL
(	NULL
IIL.2	NULL
)	NULL
is	NULL
of	NULL
paternal	NULL
origin	NULL
,	NULL
our	NULL
data	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
de	NULL
novo	NULL
mutation	NULL
occurred	NULL
in	NULL
the	NULL
twins	NULL
'	NULL
father	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
fibroblast	NULL
samples	NULL
,	NULL
analysis	NULL
of	NULL
DNA	NULL
extracted	NULL
from	NULL
lymphoid	NULL
cell	NULL
lines	NULL
of	NULL
the	NULL
twins	NULL
did	NULL
not	NULL
show	NULL
opposite	NULL
inactivation	NULL
patterns	NULL
,	NULL
but	NULL
a	NULL
slightly	NULL
preferential	NULL
inactivation	NULL
of	NULL
the	NULL
maternal	NULL
X	NULL
chromosome	NULL
in	NULL
both	NULL
twins	NULL
(	NULL
fig	NULL
5B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
good	NULL
agreement	NULL
with	NULL
the	NULL
«	NULL
-galactosidase	NULL
activity	NULL
levels	NULL
measured	NULL
in	NULL
the	NULL
two	NULL
types	NULL
of	NULL
cells	NULL
(	NULL
table	NULL
2	NULL
)	NULL
:	NULL
while	NULL
a	NULL
clear	NULL
difference	NULL
in	NULL
the	NULL
activity	NULL
levels	NULL
between	NULL
the	NULL
twins	NULL
was	NULL
apparent	NULL
in	NULL
the	NULL
fibroblasts	NULL
,	NULL
quite	NULL
similar	NULL
values	NULL
(	NULL
slightly	NULL
below	NULL
the	NULL
heterozygote	NULL
range	NULL
)	NULL
were	NULL
observed	NULL
in	NULL
lymphoid	NULL
cell	NULL
ho-mogenates	NULL
.	NULL

Discussion	NULL
This	NULL
study	NULL
reports	NULL
a	NULL
French	NULL
family	NULL
with	NULL
Fabry	NULL
disease	NULL
resulting	NULL
from	NULL
an	NULL
as	NULL
yet	NULL
undescribed	NULL
mutation	NULL
.	NULL

A	NULL
series	NULL
of	NULL
molecular	NULL
lesions	NULL
in	NULL
the	NULL
«	NULL
-galactosidase	NULL
A	NULL
gene	NULL
causing	NULL
Fabry	NULL
disease	NULL
have	NULL
been	NULL
reported	NULL
.	NULL
``	NULL

``	NULL
``	NULL
*	NULL
Most	NULL
of	NULL
these	NULL
mutations	NULL
are	NULL
private	NULL
and	NULL
include	NULL
exonic	NULL
gene	NULL
rearrangements	NULL
,	NULL
small	NULL
deletions	NULL
and	NULL
insertions	NULL
,	NULL
mRNA	NULL
processing	NULL
defects	NULL
,	NULL
and	NULL
single	NULL
base	NULL
substitutions	NULL
.	NULL

The	NULL
single	NULL
point	NULL
mutation	NULL
we	NULL
identified	NULL
causes	NULL
a	NULL
change	NULL
in	NULL
the	NULL
charge	NULL
of	NULL
the	NULL
amino	NULL
acid	NULL
chain	NULL
and	NULL
is	NULL
therefore	NULL
very	NULL
likely	NULL
to	NULL
affect	NULL
the	NULL
-galactosidase	NULL
structure	NULL
or	NULL
function	NULL
or	NULL
both	NULL
.	NULL

A	NULL
similar	NULL
substitution	NULL
has	NULL
already	NULL
been	NULL
described	NULL
in	NULL
exon	NULL
5	NULL
at	NULL
codon	NULL
244	NULL
.	NULL
``	NULL

The	NULL
findings	NULL
of	NULL
our	NULL
enzymatic	NULL
and	NULL
molecular	NULL
studies	NULL
suggest	NULL
that	NULL
in	NULL
the	NULL
present	NULL
family	NULL
,	NULL
the	NULL
mutant	NULL
allele	NULL
arose	NULL
in	NULL
a	NULL
gamete	NULL
of	NULL
the	NULL
grandfather	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
report	NULL
is	NULL
the	NULL
third	NULL
example	NULL
of	NULL
Fabry	NULL
disease	NULL
resulting	NULL
from	NULL
a	NULL
de	NULL
novo	NULL
mutation	NULL
.	NULL

Indeed	NULL
,	NULL
out	NULL
of	NULL
the	NULL
many	NULL
mutations	NULL
identified	NULL
in	NULL
Fabry	NULL
disease	NULL
,	NULL
only	NULL
two	NULL
instances	NULL
of	NULL
de	NULL
novo	NULL
mutations	NULL
have	NULL
been	NULL
reported	NULL
,	NULL
one	NULL
partial	NULL
deletion	NULL
``	NULL
and	NULL
one	NULL
complex	NULL
mutation	NULL
in	NULL
exon	NULL
5	NULL
.	NULL
``	NULL

Analysis	NULL
of	NULL
the	NULL
polymorphism	NULL
at	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
locus	NULL
indicated	NULL
that	NULL
the	NULL
Fabry	NULL
mutation	NULL
found	NULL
in	NULL
the	NULL
twins	NULL
and	NULL
the	NULL
hemizygous	NULL
child	NULL
was	NULL
carried	NULL
by	NULL
the	NULL
X	NULL
chromosome	NULL
inherited	NULL
from	NULL
the	NULL
grandfather	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
de	NULL
Discordant	NULL
expression	NULL
of	NULL
Fabry	NULL
disease	NULL
in	NULL
MZ	NULL
twins	NULL
novo	NULL
mutation	NULL
in	NULL
the	NULL
MZ	NULL
twins	NULL
was	NULL
of	NULL
paternal	NULL
origin	NULL
.	NULL

Whether	NULL
this	NULL
defect	NULL
occurred	NULL
during	NULL
meiosis	NULL
or	NULL
earlier	NULL
in	NULL
mitosis	NULL
of	NULL
the	NULL
germ	NULL
cells	NULL
(	NULL
causing	NULL
gonadal	NULL
mosaicism	NULL
)	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Monozygosity	NULL
of	NULL
the	NULL
twins	NULL
was	NULL
established	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
several	NULL
criteria	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
physical	NULL
similarities	NULL
and	NULL
identity	NULL
of	NULL
erythrocyte	NULL
and	NULL
HLA	NULL
groups	NULL
,	NULL
``	NULL
``	NULL
the	NULL
twin	NULL
sisters	NULL
shared	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
polymorphic	NULL
STR	NULL
markers	NULL
(	NULL
table	NULL
1	NULL
)	NULL
.	NULL

Although	NULL
monozygotic	NULL
,	NULL
the	NULL
twins	NULL
exhibited	NULL
discordant	NULL
expression	NULL
of	NULL
Fabry	NULL
disease	NULL
.	NULL

While	NULL
they	NULL
were	NULL
both	NULL
shown	NULL
to	NULL
be	NULL
heterozygous	NULL
for	NULL
(	NULL
-galactosidase	NULL
A	NULL
deficiency	NULL
,	NULL
only	NULL
one	NULL
twin	NULL
had	NULL
clinical	NULL
signs	NULL
and	NULL
symptoms	NULL
of	NULL
Fabry	NULL
disease	NULL
.	NULL

Two	NULL
other	NULL
female	NULL
twin	NULL
pairs	NULL
heterozygous	NULL
for	NULL
Fabry	NULL
disease	NULL
have	NULL
previously	NULL
been	NULL
reported	NULL
in	NULL
an	NULL
English	NULL
``	NULL
``	NULL
and	NULL
a	NULL
Dutch	NULL
``	NULL
family	NULL
.	NULL

Although	NULL
their	NULL
monozygosity	NULL
has	NULL
not	NULL
been	NULL
established	NULL
,	NULL
these	NULL
patients	NULL
also	NULL
seemed	NULL
to	NULL
exhibit	NULL
different	NULL
expression	NULL
of	NULL
the	NULL
disease	NULL
.	NULL
``	NULL

The	NULL
observed	NULL
phenotypic	NULL
discordance	NULL
between	NULL
the	NULL
twins	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
X	NULL
inactivation	NULL
dissimilarities	NULL
.	NULL

Indeed	NULL
,	NULL
uneven	NULL
lyonisa-tion	NULL
between	NULL
the	NULL
twin	NULL
sisters	NULL
,	NULL
that	NULL
is	NULL
,	NULL
a	NULL
different	NULL
pattern	NULL
of	NULL
X	NULL
inactivation	NULL
at	NULL
the	NULL
androgen	NULL
receptor	NULL
locus	NULL
,	NULL
was	NULL
found	NULL
in	NULL
skin	NULL
fibroblasts	NULL
.	NULL

This	NULL
type	NULL
of	NULL
analysis	NULL
clearly	NULL
showed	NULL
that	NULL
the	NULL
paternally	NULL
derived	NULL
X	NULL
chromosome	NULL
was	NULL
active	NULL
in	NULL
most	NULL
skin	NULL
cells	NULL
of	NULL
the	NULL
Fabry	NULL
diseased	NULL
twin	NULL
while	NULL
the	NULL
maternally	NULL
derived	NULL
X	NULL
was	NULL
active	NULL
in	NULL
the	NULL
unaffected	NULL
twin	NULL
.	NULL

This	NULL
X	NULL
inactivation	NULL
pattern	NULL
is	NULL
likely	NULL
to	NULL
occur	NULL
also	NULL
in	NULL
the	NULL
target	NULL
cells	NULL
of	NULL
Fabry	NULL
disease	NULL
,	NULL
that	NULL
is	NULL
,	NULL
endothelial	NULL
and	NULL
smooth	NULL
muscle	NULL
cells	NULL
,	NULL
``	NULL
since	NULL
the	NULL
latter	NULL
cells	NULL
and	NULL
skin	NULL
fibroblasts	NULL
have	NULL
the	NULL
same	NULL
mesodermal	NULL
origin	NULL
.	NULL

While	NULL
completely	NULL
opposite	NULL
inactivation	NULL
patterns	NULL
were	NULL
noted	NULL
in	NULL
skin	NULL
fibroblasts	NULL
of	NULL
our	NULL
twins	NULL
,	NULL
the	NULL
patterns	NULL
of	NULL
methylation	NULL
in	NULL
the	NULL
lymphoid	NULL
cells	NULL
were	NULL
not	NULL
perfectly	NULL
random	NULL
but	NULL
were	NULL
comparable	NULL
in	NULL
both	NULL
sisters	NULL
.	NULL

Several	NULL
hypotheses	NULL
may	NULL
account	NULL
for	NULL
the	NULL
discrepancy	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

First	NULL
,	NULL
different	NULL
tissues	NULL
may	NULL
show	NULL
different	NULL
patterns	NULL
of	NULL
X	NULL
inactivation	NULL
.	NULL

Second	NULL
,	NULL
a	NULL
selective	NULL
effect	NULL
in	NULL
vitro	NULL
may	NULL
have	NULL
resulted	NULL
in	NULL
significant	NULL
clonal	NULL
outgrowth	NULL
of	NULL
lymphoblasts	NULL
in	NULL
culture	NULL
,	NULL
as	NULL
previously	NULL
re-ported	NULL
.	NULL

``	NULL
*	NULL
Finally	NULL
,	NULL
it	NULL
has	NULL
been	NULL
postulated	NULL
that	NULL
the	NULL
random	NULL
inactivation	NULL
status	NULL
in	NULL
lymphocytes	NULL
could	NULL
result	NULL
from	NULL
shared	NULL
fetal	NULL
circulation	NULL
of	NULL
lymphocyte	NULL
precursors	NULL
.	NULL
``	NULL

Accordingly	NULL
,	NULL
analysis	NULL
of	NULL
the	NULL
X	NULL
inactivation	NULL
patterns	NULL
in	NULL
a	NULL
cell	NULL
type	NULL
other	NULL
than	NULL
cultured	NULL
fibroblasts	NULL
or	NULL
lymphob-lasts	NULL
,	NULL
for	NULL
example	NULL
,	NULL
peripheral	NULL
blood	NULL
leucocytes	NULL
or	NULL
lymphocytes	NULL
,	NULL
was	NULL
not	NULL
performed	NULL
because	NULL
concordant	NULL
patterns	NULL
of	NULL
methylation	NULL
in	NULL
lymphocytes	NULL
(	NULL
but	NULL
not	NULL
in	NULL
the	NULL
skin	NULL
)	NULL
have	NULL
previously	NULL
been	NULL
reported	NULL
in	NULL
a	NULL
twin	NULL
pair	NULL
'	NULL
and	NULL
because	NULL
one	NULL
of	NULL
our	NULL
twins	NULL
is	NULL
no	NULL
longer	NULL
available	NULL
.	NULL

Discordant	NULL
expression	NULL
of	NULL
X	NULL
linked	NULL
disorders	NULL
in	NULL
monozygotic	NULL
twin	NULL
females	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
at	NULL
least	NULL
22	NULL
female	NULL
twin	NULL
pairs	NULL
heterozygous	NULL
for	NULL
Duchenne	NULL
muscular	NULL
dystrophy	NULL
,	NULL
deuter-anomaly	NULL
,	NULL
G6PD	NULL
deficiency	NULL
,	NULL
haemophilia	NULL
B	NULL
,	NULL
fragile	NULL
X	NULL
syndrome	NULL
,	NULL
and	NULL
Hunter	NULL
disease	NULL
.	NULL

*	NULL
``	NULL
Our	NULL
observation	NULL
adds	NULL
another	NULL
twin	NULL
pair	NULL
with	NULL
markedly	NULL
different	NULL
X	NULL
inactivation	NULL
patterns	NULL
for	NULL
an	NULL
hitherto	NULL
-	NULL
undescribed	NULL
X	NULL
linked	NULL
_	NULL
trait	NULL
,	NULL
-galactosidase	NULL
A	NULL
deficiency	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
previ-	NULL
687	NULL
ously	NULL
noted	NULL
,	NULL
``	NULL
'°	NULL
it	NULL
appears	NULL
that	NULL
concordant	NULL
expression	NULL
of	NULL
(	NULL
at	NULL
least	NULL
seven	NULL
)	NULL
X	NULL
linked	NULL
disorders	NULL
in	NULL
MZ	NULL
female	NULL
heterozygotes	NULL
has	NULL
never	NULL
been	NULL
reported	NULL
.	NULL

This	NULL
finding	NULL
has	NULL
led	NULL
to	NULL
the	NULL
pos-tulation	NULL
that	NULL
MZ	NULL
twinning	NULL
events	NULL
and	NULL
uneven	NULL
X	NULL
inactivation	NULL
are	NULL
connected	NULL
.	NULL
``	NULL

***	NULL
*	NULL
Indeed	NULL
,	NULL
if	NULL
X	NULL
inactivation	NULL
occurred	NULL
independently	NULL
in	NULL
each	NULL
female	NULL
MZ	NULL
twin	NULL
,	NULL
creation	NULL
of	NULL
opposite	NULL
patterns	NULL
of	NULL
non-random	NULL
X	NULL
inactivation	NULL
would	NULL
be	NULL
unlikely	NULL
.	NULL

Accordingly	NULL
,	NULL
it	NULL
seems	NULL
that	NULL
X	NULL
inactivation	NULL
precedes	NULL
MZ	NULL
twinning	NULL
,	NULL
and	NULL
that	NULL
predominant	NULL
inactivation	NULL
of	NULL
the	NULL
normal	NULL
X	NULL
in	NULL
one	NULL
of	NULL
the	NULL
twins	NULL
frequently	NULL
accompanies	NULL
the	NULL
twinning	NULL
process	NULL
.	NULL

One	NULL
possible	NULL
mechanism	NULL
for	NULL
non-randomness	NULL
would	NULL
be	NULL
the	NULL
asymmetrical	NULL
splitting	NULL
of	NULL
the	NULL
inner	NULL
cell	NULL
mass	NULL
.	NULL
``	NULL

*	NULL
The	NULL
first	NULL
and	NULL
second	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
F	NULL
Giordano	NULL
and	NULL
M	NULL
C	NULL
Marguery	NULL
(	NULL
Service	NULL
de	NULL
Der-matologie	NULL
,	NULL
CHU	NULL
Purpan	NULL
,	NULL
Toulouse	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
patients	NULL
'	NULL
specimens	NULL
and	NULL
Drs	NULL
G	NULL
Bourrouillou	NULL
and	NULL
P	NULL
Calvas	NULL
(	NULL
Service	NULL
de	NULL
Génétique	NULL
Médicale	NULL
,	NULL
CHU	NULL
Purpan	NULL
,	NULL
Toulouse	NULL
)	NULL
for	NULL
helpful	NULL
discussion	NULL
.	NULL

The	NULL
expert	NULL
technical	NULL
assistance	NULL
of	NULL
Mrs	NULL
M	NULL
J	NULL
Bonnafé	NULL
,	NULL
Mrs	NULL
M	NULL
J	NULL
Nonnon	NULL
,	NULL
and	NULL
Mrs	NULL
M	NULL
A	NULL
Berges	NULL
is	NULL
acknowledged	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
J	NULL
P	NULL
Esteve	NULL
for	NULL
densitometric	NULL
analyses	NULL
and	NULL
J	NULL
C	NULL
Thiers	NULL
for	NULL
illustrations	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
INSERM	NULL
(	NULL
CJF	NULL
9206	NULL
)	NULL
and	NULL
the	NULL
association	NULL
``	NULL
Vaincre	NULL
les	NULL
Maladies	NULL
Lysosomales	NULL
``	NULL
.	NULL

1	NULL
Lyon	NULL
MF	NULL
.	NULL

Gene	NULL
action	NULL
in	NULL
the	NULL
X-chromosome	NULL
of	NULL
the	NULL
mouse	NULL
.	NULL

Nature	NULL
1961	NULL
;	NULL
190:372-3	NULL
.	NULL

2	NULL
Grant	NULL
SG	NULL
,	NULL
Chapman	NULL
VM	NULL
.	NULL

Mechanisms	NULL
of	NULL
X-chromosome	NULL
regulation	NULL
.	NULL

Annu	NULL
Rev	NULL
Genet	NULL
1988	NULL
;	NULL
22:199-233	NULL
.	NULL

3	NULL
Willard	NULL
HF	NULL
.	NULL

The	NULL
sex	NULL
chromosomes	NULL
and	NULL
X	NULL
chromosome	NULL
inactivation	NULL
.	NULL

In	NULL
:	NULL
Scriver	NULL
CR	NULL
,	NULL
Beaudet	NULL
AL	NULL
,	NULL
Sly	NULL
WS	NULL
,	NULL
Valle	NULL
D	NULL
,	NULL
eds	NULL
.	NULL

The	NULL
metabolic	NULL
and	NULL
molecular	NULL
bases	NULL
of	NULL
inherited	NULL
disease	NULL
.	NULL

7th	NULL
ed	NULL
.	NULL

New	NULL
York	NULL
:	NULL
McGraw-Hill	NULL
,	NULL
1995:719-37	NULL
.	NULL

4	NULL
Jorgensen	NULL
AL	NULL
,	NULL
Philip	NULL
J	NULL
,	NULL
Raskind	NULL
WH	NULL
,	NULL
er	NULL
al	NULL
.	NULL

Different	NULL
patterns	NULL
of	NULL
X	NULL
inactivation	NULL
in	NULL
MZ	NULL
twins	NULL
discordant	NULL
for	NULL
red-green	NULL
color-vision	NULL
deficiency	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
1992	NULL
;	NULL
51:291-8	NULL
.	NULL

5	NULL
Winchester	NULL
B	NULL
,	NULL
Young	NULL
E	NULL
,	NULL
Geddes	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Female	NULL
twin	NULL
with	NULL
Hunter	NULL
disease	NULL
due	NULL
to	NULL
nonrandom	NULL
inactivation	NULL
of	NULL
the	NULL
X	NULL
chromosome	NULL
:	NULL
a	NULL
consequence	NULL
of	NULL
twinning	NULL
.	NULL

Am	NULL
J	NULL
Med	NULL
Gene	NULL
:	NULL
1992	NULL
;	NULL
44:834-8	NULL
.	NULL

6	NULL
Abbadi	NULL
N	NULL
,	NULL
Philippe	NULL
C	NULL
,	NULL
Chery	NULL
M	NULL
,	NULL
er	NULL
al	NULL
.	NULL

Additional	NULL
case	NULL
of	NULL
female	NULL
monozygotic	NULL
twins	NULL
discordant	NULL
for	NULL
the	NULL
clinical	NULL
manifestations	NULL
of	NULL
Duchenne	NULL
muscular	NULL
dystrophy	NULL
due	NULL
to	NULL
opposite	NULL
X-chromosome	NULL
inactivation	NULL
.	NULL

Am	NULL
J	NULL
Med	NULL
Genet	NULL
1994	NULL
;	NULL
52:198-206	NULL
.	NULL

7	NULL
Kruyer	NULL
H	NULL
,	NULL
Mila	NULL
M	NULL
,	NULL
Glover	NULL
G	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Fragile	NULL
X	NULL
syndrome	NULL
and	NULL
the	NULL
(	NULL
CGG	NULL
)	NULL
,	NULL
mutation	NULL
:	NULL
two	NULL
families	NULL
with	NULL
discordant	NULL
MZ	NULL
twins	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
1994	NULL
;	NULL
54:437-42	NULL
.	NULL

8	NULL
James	NULL
WH	NULL
.	NULL

Anomalous	NULL
X	NULL
chromosome	NULL
inactivation	NULL
:	NULL
the	NULL
link	NULL
between	NULL
female	NULL
zygotes	NULL
,	NULL
monozygotic	NULL
twinning	NULL
,	NULL
and	NULL
neural	NULL
tube	NULL
defects	NULL
?	NULL

7	NULL
Med	NULL
Genet	NULL
1988	NULL
;	NULL
25:213-14	NULL
.	NULL

9	NULL
Richards	NULL
CS	NULL
,	NULL
Watkins	NULL
SC	NULL
,	NULL
Hoffman	NULL
EP	NULL
,	NULL
er	NULL
al	NULL
.	NULL

Skewed	NULL
X	NULL
inactivation	NULL
in	NULL
a	NULL
female	NULL
MZ	NULL
twin	NULL
results	NULL
in	NULL
Duchenne	NULL
muscular	NULL
dystrophy	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Gener	NULL
1990	NULL
;	NULL
46:672-81	NULL
.	NULL

10	NULL
Nance	NULL
WE	NULL
.	NULL

Do	NULL
twin	NULL
Lyons	NULL
have	NULL
larger	NULL
spots	NULL
?	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
1990	NULL
;	NULL
46:646-8	NULL
.	NULL

Lubinski	NULL
MS	NULL
,	NULL
Hall	NULL
JG	NULL
.	NULL

Genomic	NULL
imprinting	NULL
,	NULL
monozygous	NULL
twinning	NULL
and	NULL
X	NULL
inactivation	NULL
.	NULL

Lancer	NULL
1991	NULL
;	NULL
337:1288	NULL
.	NULL

Desnick	NULL
RJ	NULL
,	NULL
Ioannou	NULL
YA	NULL
,	NULL
Eng	NULL
CM	NULL
.	NULL

-Galactosidase	NULL
A	NULL
defi-ciency	NULL
:	NULL
Fabry	NULL
disease	NULL
.	NULL

In	NULL
:	NULL
Scriver	NULL
CR	NULL
,	NULL
Beaudet	NULL
AL	NULL
,	NULL
Sly	NULL
WS	NULL
,	NULL
Valle	NULL
D	NULL
,	NULL
eds	NULL
.	NULL

The	NULL
merabolic	NULL
and	NULL
molecular	NULL
bases	NULL
of	NULL
inherited	NULL
disease	NULL
.	NULL

7th	NULL
ed	NULL
.	NULL

New	NULL
York	NULL
:	NULL
McGraw-Hill	NULL
,	NULL
1995:2741-84	NULL
.	NULL

13	NULL
Bishop	NULL
DF	NULL
,	NULL
Calhoun	NULL
DH	NULL
,	NULL
Bernstein	NULL
HS	NULL
,	NULL
ef	NULL
al	NULL
.	NULL

Human	NULL
o-galactosidase	NULL
A	NULL
:	NULL
nucleotide	NULL
sequence	NULL
of	NULL
a	NULL
cDNA	NULL
clone	NULL
encoding	NULL
the	NULL
mature	NULL
enzyme	NULL
.	NULL

Proc	NULL
Nat	NULL
Acad	NULL
Sci	NULL
USA	NULL
1986	NULL
;	NULL
83:4859-63	NULL
.	NULL

14	NULL
Bishop	NULL
DF	NULL
,	NULL
Kornreich	NULL
R	NULL
,	NULL
Desnick	NULL
RJ	NULL
.	NULL

Structural	NULL
organization	NULL
of	NULL
the	NULL
human	NULL
o-galactosidase	NULL
A	NULL
gene	NULL
:	NULL
further	NULL
evidence	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
1988	NULL
;	NULL
85:3903-7	NULL
.	NULL

15	NULL
Romeo	NULL
G	NULL
,	NULL
Migeon	NULL
BR	NULL
.	NULL

Genetic	NULL
inactivation	NULL
of	NULL
the	NULL
O-galactosidase	NULL
locus	NULL
in	NULL
carriers	NULL
of	NULL
Fabry	NULL
's	NULL
disease	NULL
.	NULL

Science	NULL
1970	NULL
;	NULL
170:180-1	NULL
.	NULL

16	NULL
Marguery	NULL
MC	NULL
,	NULL
Giordano	NULL
F	NULL
,	NULL
Parant	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Fabry	NULL
's	NULL
disease	NULL
:	NULL
heterozygous	NULL
form	NULL
of	NULL
different	NULL
expression	NULL
in	NULL
two	NULL
monozygous	NULL
twin	NULL
sisters	NULL
.	NULL

Dermatology	NULL
1993	NULL
;	NULL
187:9-15	NULL
.	NULL

17	NULL
Skoog	NULL
WA	NULL
,	NULL
Beck	NULL
WS	NULL
.	NULL

Studies	NULL
on	NULL
fibrinogen	NULL
,	NULL
dextran	NULL
and	NULL
phytohemagglutinin	NULL
methods	NULL
of	NULL
isolating	NULL
leukocytes	NULL
.	NULL

Blood	NULL
1956	NULL
;	NULL
11:436-54	NULL
.	NULL

18	NULL
Neitzel	NULL
H.	NULL
A	NULL
routine	NULL
method	NULL
for	NULL
the	NULL
establishment	NULL
of	NULL
permanent	NULL
growing	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
.	NULL

Hum	NULL
Genet	NULL
1986	NULL
;	NULL
73:320-6	NULL
.	NULL

19	NULL
Salvayre	NULL
R	NULL
,	NULL
Négre	NULL
A	NULL
,	NULL
Maret	NULL
A	NULL
,	NULL
er	NULL
al	NULL
.	NULL

Separation	NULL
and	NULL
properties	NULL
of	NULL
molecular	NULL
forms	NULL
of	NULL
a-galactosidase	NULL
and	NULL
-N-acetylgalactosaminidase	NULL
from	NULL
blood	NULL
lymphocytes	NULL
and	NULL
lymphoid	NULL
cell	NULL
lines	NULL
transformed	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1981	NULL
;	NULL
659:445-56.	NULL
w	NULL
--	NULL
1	NULL
bo	NULL
688	NULL
20	NULL
2	NULL
fad	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
3	NULL
hat	NULL
32	NULL
33	NULL
Redonnet-Vernhet	NULL
,	NULL
Ploos	NULL
van	NULL
Amstel	NULL
,	NULL
Jansen	NULL
,	NULL
Wevers	NULL
,	NULL
Salvayre	NULL
,	NULL
Levade	NULL
Levade	NULL
T	NULL
,	NULL
Giordano	NULL
F	NULL
,	NULL
Maret	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Different	NULL
phenotypic	NULL
expression	NULL
of	NULL
Fabry	NULL
disease	NULL
in	NULL
female	NULL
monozygotic	NULL
twins	NULL
.	NULL

J	NULL
Inherited	NULL
Metab	NULL
Dis	NULL
1990	NULL
;	NULL
14:105-6	NULL
.	NULL

Spence	NULL
MW	NULL
,	NULL
Goldbloom	NULL
AL	NULL
,	NULL
Burgess	NULL
JK	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Heterozygote	NULL
detection	NULL
in	NULL
angiokeratoma	NULL
corporis	NULL
diffusum	NULL
(	NULL
Anderson-Fabry	NULL
disease	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
plasma	NULL
,	NULL
leucocytes	NULL
,	NULL
and	NULL
hair	NULL
follicles	NULL
.	NULL

J	NULL
Med	NULL
Gener	NULL
1977	NULL
;	NULL
14:91-9	NULL
.	NULL

Beaudet	NULL
AL	NULL
,	NULL
Caskey	NULL
CT	NULL
.	NULL

Detection	NULL
of	NULL
Fabry	NULL
's	NULL
disease	NULL
heterozygotes	NULL
by	NULL
hair	NULL
root	NULL
analysis	NULL
.	NULL

Clin	NULL
Gener	NULL
1978	NULL
;	NULL
13:251-8	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T.	NULL
Molecular	NULL
cloning	NULL
.	NULL

A	NULL
laboratory	NULL
manual	NULL
.	NULL

2nd	NULL
ed	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
1989	NULL
.	NULL

Hammond	NULL
HA	NULL
,	NULL
Jin	NULL
L	NULL
,	NULL
Zhong	NULL
Y	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Evaluation	NULL
of	NULL
13	NULL
short	NULL
tandem	NULL
repeat	NULL
loci	NULL
for	NULL
use	NULL
in	NULL
personal	NULL
identification	NULL
appli-cations	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
1994	NULL
;	NULL
55:175-89	NULL
.	NULL

Ploos	NULL
van	NULL
Amstel	NULL
JK	NULL
,	NULL
Jansen	NULL
RPM	NULL
,	NULL
de	NULL
Jong	NULL
JGN	NULL
,	NULL
er	NULL
al	NULL
.	NULL

Six	NULL
novel	NULL
mutations	NULL
in	NULL
the	NULL
A	NULL
gene	NULL
in	NULL
families	NULL
with	NULL
Fabry	NULL
disease	NULL
.	NULL

Hum	NULL
Mol	NULL
Gener	NULL
1994	NULL
;	NULL
3:503-5	NULL
.	NULL

Allen	NULL
RC	NULL
,	NULL
Zoghbi	NULL
HY	NULL
,	NULL
Moseley	NULL
AB	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Methylation	NULL
of	NULL
Hpall	NULL
and	NULL
Hhal	NULL
sites	NULL
near	NULL
the	NULL
polymorphic	NULL
CAG	NULL
repeat	NULL
in	NULL
the	NULL
human	NULL
androgen-receptor	NULL
gene	NULL
correlates	NULL
with	NULL
X	NULL
chromosome	NULL
inactivation	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
1992	NULL
;	NULL
51:1229-39	NULL
.	NULL

Bernstein	NULL
HS	NULL
,	NULL
Bishop	NULL
DF	NULL
,	NULL
Astrin	NULL
KH	NULL
,	NULL
er	NULL
al	NULL
.	NULL

Fabry	NULL
disease	NULL
:	NULL
six	NULL
gene	NULL
rearrangements	NULL
and	NULL
an	NULL
exonic	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
o-galactosidase	NULL
gene	NULL
.	NULL

7	NULL
Clin	NULL
Invest	NULL
1989	NULL
;	NULL
83	NULL
:	NULL
1390-9	NULL
.	NULL

Fukuhara	NULL
Y	NULL
,	NULL
Sakuraba	NULL
H	NULL
,	NULL
Oshima	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Partial	NULL
deletion	NULL
of	NULL
human	NULL
-galactosidase	NULL
A	NULL
gene	NULL
in	NULL
Fabry	NULL
disease	NULL
:	NULL
direct	NULL
repeat	NULL
sequences	NULL
as	NULL
a	NULL
possible	NULL
cause	NULL
of	NULL
slipped	NULL
mispairing	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
1990	NULL
;	NULL
170:296-300	NULL
.	NULL

Koide	NULL
T	NULL
,	NULL
Ishiura	NULL
M	NULL
,	NULL
Iwai	NULL
K	NULL
,	NULL
er	NULL
al	NULL
.	NULL

A	NULL
case	NULL
of	NULL
Fabry	NULL
's	NULL
disease	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
no	NULL
o-galactosidase	NULL
A	NULL
activity	NULL
caused	NULL
by	NULL
a	NULL
single	NULL
amino	NULL
acid	NULL
substitution	NULL
of	NULL
Pro-40	NULL
by	NULL
Ser	NULL
.	NULL

FEBS	NULL
Lert	NULL
1990	NULL
;	NULL
259:353-6	NULL
.	NULL

Kornreich	NULL
R	NULL
,	NULL
Bishop	NULL
DF	NULL
,	NULL
Desnick	NULL
RJ	NULL
.	NULL

«	NULL
-Galactosidase	NULL
A	NULL
gene	NULL
rearrangements	NULL
causing	NULL
Fabry	NULL
disease	NULL
.	NULL

Identification	NULL
of	NULL
short	NULL
direct	NULL
repeats	NULL
at	NULL
breakpoints	NULL
in	NULL
an	NULL
Alu-rich	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
1990	NULL
;	NULL
265:9319-26	NULL
.	NULL

Sakuraba	NULL
H	NULL
,	NULL
Oshima	NULL
A	NULL
,	NULL
Fukuhara	NULL
Y	NULL
,	NULL
et	NULL
a/	NULL
.	NULL

Identification	NULL
of	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
-galactosidase	NULL
A	NULL
gene	NULL
in	NULL
classical	NULL
and	NULL
atypical	NULL
hemizygotes	NULL
with	NULL
Fabry	NULL
disease	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
1990	NULL
;	NULL
47:784-9	NULL
.	NULL

Ishii	NULL
S	NULL
,	NULL
Sakuraba	NULL
H	NULL
,	NULL
Shimmoto	NULL
M	NULL
,	NULL
er	NULL
al	NULL
.	NULL

Fabry	NULL
disease	NULL
:	NULL
detection	NULL
of	NULL
13-bp	NULL
deletion	NULL
in	NULL
-galactosidase	NULL
A	NULL
gene	NULL
and	NULL
its	NULL
application	NULL
to	NULL
gene	NULL
diagnosis	NULL
of	NULL
heterozygotes	NULL
.	NULL

Ann	NULL
Neurol	NULL
1991	NULL
;	NULL
29:560-4	NULL
.	NULL

Von	NULL
Scheidt	NULL
W	NULL
,	NULL
Eng	NULL
CM	NULL
,	NULL
Fitzmaurice	NULL
TF	NULL
,	NULL
et	NULL
al	NULL
.	NULL

An	NULL
atypical	NULL
variant	NULL
of	NULL
Fabry	NULL
's	NULL
disease	NULL
with	NULL
manifestations	NULL
confined	NULL
to	NULL
the	NULL
myocardium	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
1991	NULL
;	NULL
324:395-9	NULL
.	NULL

34	NULL
35	NULL
36	NULL
37	NULL
38	NULL
39	NULL
40	NULL
4	NULL
i	NULL
42	NULL
Ishii	NULL
S	NULL
,	NULL
Sakuraba	NULL
H	NULL
,	NULL
Suzuki	NULL
Y	NULL
.	NULL

Point	NULL
mutations	NULL
in	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
-galactosidase	NULL
A	NULL
gene	NULL
exon	NULL
6	NULL
in	NULL
an	NULL
atypical	NULL
variant	NULL
of	NULL
Fabry	NULL
disease	NULL
.	NULL

Hum	NULL
Genet	NULL
1992	NULL
;	NULL
89:29-32	NULL
.	NULL

Sakuraba	NULL
H	NULL
,	NULL
Eng	NULL
CM	NULL
,	NULL
Desnick	NULL
RJ	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Invariant	NULL
exon	NULL
skilfping	NULL
in	NULL
the	NULL
human	NULL
o-galactosidase	NULL
A	NULL
pre-mRNA	NULL
:	NULL
a	NULL
G*	NULL
to	NULL
T	NULL
substitution	NULL
in	NULL
a	NULL
5'-splice	NULL
site	NULL
causing	NULL
Fabry	NULL
disease	NULL
.	NULL

Genomics	NULL
1992	NULL
;	NULL
12:643-50	NULL
.	NULL

Davies	NULL
JP	NULL
,	NULL
Winchester	NULL
BG	NULL
,	NULL
Malcolm	NULL
S	NULL
$	NULL
.	NULL

Mutation	NULL
analysis	NULL
in	NULL
patients	NULL
with	NULL
the	NULL
typical	NULL
form	NULL
of	NULL
Anderson-Fabry	NULL
disease	NULL
.	NULL

Hum	NULL
Mol	NULL
Genet	NULL
1993	NULL
;	NULL
2:1051-3	NULL
.	NULL

Eng	NULL
CM	NULL
,	NULL
Resnick-Silverman	NULL
LA	NULL
,	NULL
Nichaus	NULL
DJ	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Nature	NULL
and	NULL
frequency	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
o-galactosidase	NULL
A	NULL
gene	NULL
that	NULL
cause	NULL
Fabry	NULL
disease	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Gener	NULL
1993	NULL
;	NULL
53:1186-97	NULL
.	NULL

Davies	NULL
J	NULL
,	NULL
Christomanou	NULL
H	NULL
,	NULL
Winchester	NULL
B	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Detection	NULL
of	NULL
8	NULL
new	NULL
mutations	NULL
in	NULL
the	NULL
o-galactosidase	NULL
A	NULL
gene	NULL
in	NULL
Fabry	NULL
disease	NULL
.	NULL

Hum	NULL
Mol	NULL
Genet	NULL
1994	NULL
;	NULL
3:667-9	NULL
.	NULL

Eng	NULL
CM	NULL
,	NULL
Nichaus	NULL
DJ	NULL
,	NULL
Enriquez	NULL
AL	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Fabry	NULL
disease	NULL
:	NULL
twenty-three	NULL
mutations	NULL
including	NULL
sense	NULL
and	NULL
antisense	NULL
CpG	NULL
alterations	NULL
and	NULL
identification	NULL
of	NULL
a	NULL
deletional	NULL
hot-spot	NULL
in	NULL
the	NULL
O-galactosidase	NULL
A	NULL
gene	NULL
.	NULL

Hum	NULL
Mol	NULL
Genet	NULL
1994	NULL
;	NULL
3:1795-9	NULL
.	NULL

Eng	NULL
CM	NULL
,	NULL
Desnick	NULL
RJ	NULL
.	NULL

Molecular	NULL
basis	NULL
of	NULL
Fabry	NULL
disease	NULL
:	NULL
mutations	NULL
-	NULL
and	NULL
-	NULL
polymorphisms	NULL
-	NULL
in	NULL
-	NULL
the	NULL
-	NULL
human	NULL
o-galactosidase	NULL
A	NULL
gene	NULL
.	NULL

Hum	NULL
Mutat	NULL
1994	NULL
;	NULL
3:103-11	NULL
.	NULL

Kawanishi	NULL
C	NULL
,	NULL
Osaka	NULL
H	NULL
,	NULL
Inoue	NULL
K	NULL
,	NULL
er	NULL
al	NULL
.	NULL

New	NULL
point	NULL
mutation	NULL
(	NULL
R301X	NULL
)	NULL
of	NULL
the	NULL
-galactosidase	NULL
A	NULL
gene	NULL
causing	NULL
Fabry	NULL
disease	NULL
.	NULL

Hum	NULL
Mutat	NULL
1995	NULL
;	NULL
6:186-7	NULL
.	NULL

Hill	NULL
JA	NULL
,	NULL
Wevers	NULL
RA	NULL
,	NULL
Davies	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
o-galactosidase	NULL
A	NULL
gene	NULL
.	NULL

10th	NULL
ESGLD	NULL
meeting	NULL
,	NULL
Cambridge	NULL
,	NULL
1995	NULL
(	NULL
Abstract	NULL
)	NULL
.	NULL

43	NULL
Johnston	NULL
AW	NULL
,	NULL
Warland	NULL
BJ	NULL
,	NULL
Weller	NULL
SDV	NULL
.	NULL

Genetic	NULL
aspects	NULL
of	NULL
44	NULL
45	NULL
46	NULL
47	NULL
angiokeratoma	NULL
corporis	NULL
diffusum	NULL
.	NULL

Ann	NULL
Hum	NULL
Genet	NULL
1966	NULL
;	NULL
30:25-41	NULL
.	NULL

Hamers	NULL
MN	NULL
,	NULL
Wise	NULL
D	NULL
,	NULL
Ejiofor	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Relationship	NULL
between	NULL
biochemical	NULL
and	NULL
clinical	NULL
features	NULL
in	NULL
an	NULL
English	NULL
Anderson-Fabry	NULL
family	NULL
.	NULL

Acta	NULL
Med	NULL
Scand	NULL
1979	NULL
;	NULL
206:5-10	NULL
.	NULL

Rietra	NULL
PJGM	NULL
,	NULL
Brouwer-Kelder	NULL
EM	NULL
,	NULL
De	NULL
Groot	NULL
WP	NULL
,	NULL
et	NULL
a/	NULL
.	NULL

The	NULL
use	NULL
of	NULL
biochemical	NULL
parameters	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
carriers	NULL
of	NULL
Fabry	NULL
's	NULL
disease	NULL
.	NULL

J	NULL
Mol	NULL
Med	NULL
1976	NULL
;	NULL
1:237-55	NULL
.	NULL

Migeon	NULL
BR	NULL
,	NULL
Axelman	NULL
J	NULL
,	NULL
Stetten	NULL
G.	NULL
Clonal	NULL
evolution	NULL
in	NULL
human	NULL
lymphoblast	NULL
cultures	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
1988	NULL
;	NULL
42:742-7	NULL
.	NULL

Lupski	NULL
JR	NULL
,	NULL
Garcia	NULL
CA	NULL
,	NULL
Zoghbi	NULL
HY	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Discordance	NULL
of	NULL
muscular	NULL
dystrophy	NULL
in	NULL
monozygotic	NULL
female	NULL
twins	NULL
:	NULL
evidence	NULL
supporting	NULL
asymmetric	NULL
splitting	NULL
of	NULL
the	NULL
inner	NULL
cell	NULL
mass	NULL
in	NULL
a	NULL
manifesting	NULL
carrier	NULL
of	NULL
Duchenne	NULL
dystrophy	NULL
.	NULL

Am	NULL
J	NULL
Med	NULL
Genet	NULL
1991	NULL
;	NULL
40:354-64	NULL
.	NULL

